Remi Quirion - Publications

Affiliations: 
McGill University, Montreal, QC, Canada 

391 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Mitazaki S, Nakagawasai O, Onogi H, Watanabe K, Takahashi K, Tan-No K, Quirion R, Srivastava LK, Tadano T. Role of prefrontal cortical 5-HT receptors and serotonin transporter in the behavioral deficits in post-pubertal rats following neonatal lesion of the ventral hippocampus. Behavioural Brain Research. 112226. PMID 31521737 DOI: 10.1016/J.Bbr.2019.112226  0.72
2018 Castonguay D, Dufort-Gervais J, Ménard C, Chatterjee M, Quirion R, Bontempi B, Schneider JS, Arnsten AFT, Nairn AC, Norris CM, Ferland G, Bézard E, Gaudreau P, Lombroso PJ, Brouillette J. The Tyrosine Phosphatase STEP Is Involved in Age-Related Memory Decline. Current Biology : Cb. PMID 29576474 DOI: 10.1016/J.Cub.2018.02.047  0.72
2016 Mahar I, Albuquerque MS, Mondragon-Rodriguez S, Cavanagh C, Davoli MA, Chabot JG, Williams S, Mechawar N, Quirion R, Krantic S. Phenotypic Alterations in Hippocampal NPY- and PV-Expressing Interneurons in a Presymptomatic Transgenic Mouse Model of Alzheimer's Disease. Frontiers in Aging Neuroscience. 8: 327. PMID 28154533 DOI: 10.3389/Fnagi.2016.00327  0.68
2016 Liao R, Yan F, Zeng Z, Farhan M, Little P, Quirion R, Srivastava LK, Zheng W. Amiodarone-Induced Retinal Neuronal Cell Apoptosis Attenuated by IGF-1 via Counter Regulation of the PI3k/Akt/FoxO3a Pathway. Molecular Neurobiology. PMID 27774572 DOI: 10.1007/S12035-016-0211-X  0.72
2016 Cavanagh C, Tse YC, Nguyen HB, Krantic S, Breitner JC, Quirion R, Wong TP. Inhibiting tumor necrosis factor-α before amyloidosis prevents synaptic deficits in an Alzheimer's disease model. Neurobiology of Aging. 47: 41-49. PMID 27552480 DOI: 10.1016/J.Neurobiolaging.2016.07.009  1
2016 Zeng Z, Wang X, Bhardwaj SK, Zhou X, Little PJ, Quirion R, Srivastava LK, Zheng W. The Atypical Antipsychotic Agent, Clozapine, Protects Against Corticosterone-Induced Death of PC12 Cells by Regulating the Akt/FoxO3a Signaling Pathway. Molecular Neurobiology. PMID 27173157 DOI: 10.1007/S12035-016-9904-4  1
2016 Bouvier DS, Jones EV, Quesseveur G, Davoli MA, A Ferreira T, Quirion R, Mechawar N, Murai KK. High Resolution Dissection of Reactive Glial Nets in Alzheimer's Disease. Scientific Reports. 6: 24544. PMID 27090093 DOI: 10.1038/Srep24544  0.68
2015 Zeng Z, Wang H, Shang F, Zhou L, Little PJ, Quirion R, Zheng W. Lithium ions attenuate serum-deprivation-induced apoptosis in PC12 cells through regulation of the Akt/FoxO1 signaling pathways. Psychopharmacology. PMID 26626328 DOI: 10.1007/S00213-015-4168-7  1
2015 Wang H, Quirion R, Little PJ, Cheng Y, Feng ZP, Sun HS, Xu J, Zheng W. Forkhead Box O Transcription Factors as Possible Mediators in the Development of Major Depression. Neuropharmacology. PMID 26279492 DOI: 10.1016/J.Neuropharm.2015.08.020  1
2015 Colby-Milley J, Cavanagh C, Jego S, Breitner JC, Quirion R, Adamantidis A. Sleep-Wake Cycle Dysfunction in the TgCRND8 Mouse Model of Alzheimer's Disease: From Early to Advanced Pathological Stages. Plos One. 10: e0130177. PMID 26076358 DOI: 10.1371/Journal.Pone.0130177  1
2015 Dumont Y, Bastianetto S, Duranton A, Breton L, Quirion R. Immunohistochemical distribution of neuropeptide Y, peptide YY, pancreatic polypeptide-like immunoreactivity and their receptors in the epidermal skin of healthy women. Peptides. 70: 7-16. PMID 26002416 DOI: 10.1016/J.Peptides.2015.05.002  0.56
2015 Ménard C, Gaudreau P, Quirion R. Signaling pathways relevant to cognition-enhancing drug targets. Handbook of Experimental Pharmacology. 228: 59-98. PMID 25977080 DOI: 10.1007/978-3-319-16522-6_3  0.72
2015 Albuquerque MS, Mahar I, Davoli MA, Chabot JG, Mechawar N, Quirion R, Krantic S. Regional and sub-regional differences in hippocampal GABAergic neuronal vulnerability in the TgCRND8 mouse model of Alzheimer's disease. Frontiers in Aging Neuroscience. 7: 30. PMID 25852545 DOI: 10.3389/Fnagi.2015.00030  1
2015 Ménard C, Quirion R, Vigneault E, Bouchard S, Ferland G, El Mestikawy S, Gaudreau P. Glutamate presynaptic vesicular transporter and postsynaptic receptor levels correlate with spatial memory status in aging rat models. Neurobiology of Aging. 36: 1471-82. PMID 25556161 DOI: 10.1016/J.Neurobiolaging.2014.11.013  1
2015 Phillips AG, Hongaard-Andersen P, Moscicki RA, Sahakian B, Quirion R, Krishnan KR, Race T. Proceedings of the 2013 CINP summit: innovative partnerships to accelerate CNS drug discovery for improved patient care. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 18. PMID 25542690 DOI: 10.1093/ijnp/pyu100  1
2015 Bastianetto S, Ménard C, Quirion R. Neuroprotective action of resveratrol. Biochimica Et Biophysica Acta. 1852: 1195-1201. PMID 25281824 DOI: 10.1016/J.Bbadis.2014.09.011  0.36
2014 Dumont Y, Quirion R. Neuropeptide Y pathways in anxiety-related disorders. Biological Psychiatry. 76: 834-5. PMID 25439997 DOI: 10.1016/j.biopsych.2014.09.015  0.56
2014 Andersen PH, Moscicki R, Sahakian B, Quirion R, Krishnan R, Race T, Phillips A. Securing the future of drug discovery for central nervous system disorders. Nature Reviews. Drug Discovery. 13: 871-2. PMID 25435203 DOI: 10.1038/nrd4489  1
2014 Yu W, Bonnet M, Farso M, Ma K, Chabot JG, Martin E, Torriglia A, Guan Z, McLaurin J, Quirion R, Krantic S. The expression of apoptosis inducing factor (AIF) is associated with aging-related cell death in the cortex but not in the hippocampus in the TgCRND8 mouse model of Alzheimer's disease. Bmc Neuroscience. 15: 73. PMID 24915960 DOI: 10.1186/1471-2202-15-73  1
2014 Ménard C, Quirion R, Bouchard S, Ferland G, Gaudreau P. Glutamatergic signaling and low prodynorphin expression are associated with intact memory and reduced anxiety in rat models of healthy aging. Frontiers in Aging Neuroscience. 6: 81. PMID 24847259 DOI: 10.3389/Fnagi.2014.00081  0.72
2014 Ménard C, Herzog H, Schwarzer C, Quirion R. Possible role of dynorphins in Alzheimer's disease and age-related cognitive deficits. Neuro-Degenerative Diseases. 13: 82-5. PMID 23970097 DOI: 10.1159/000353848  1
2013 Menard C, Bastianetto S, Quirion R. Neuroprotective effects of resveratrol and epigallocatechin gallate polyphenols are mediated by the activation of protein kinase C gamma. Frontiers in Cellular Neuroscience. 7: 281. PMID 24421757 DOI: 10.3389/Fncel.2013.00281  1
2013 Ménard C, Tse YC, Cavanagh C, Chabot JG, Herzog H, Schwarzer C, Wong TP, Quirion R. Knockdown of prodynorphin gene prevents cognitive decline, reduces anxiety, and rescues loss of group 1 metabotropic glutamate receptor function in aging. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 33: 12792-804. PMID 23904614 DOI: 10.1523/Jneurosci.0290-13.2013  1
2013 Shukla M, Quirion R, Ma W. Reduced expression of pain mediators and pain sensitivity in amyloid precursor protein over-expressing CRND8 transgenic mice. Neuroscience. 250: 92-101. PMID 23850592 DOI: 10.1016/J.Neuroscience.2013.06.064  1
2013 Goutagny R, Gu N, Cavanagh C, Jackson J, Chabot JG, Quirion R, Krantic S, Williams S. Alterations in hippocampal network oscillations and theta-gamma coupling arise before Aβ overproduction in a mouse model of Alzheimer's disease. The European Journal of Neuroscience. 37: 1896-902. PMID 23773058 DOI: 10.1111/Ejn.12233  0.68
2013 Cavanagh C, Colby-Milley J, Bouvier D, Farso M, Chabot JG, Quirion R, Krantic S. βCTF-correlated burst of hippocampal TNFα occurs at a very early, pre-plaque stage in the TgCRND8 mouse model of Alzheimer's disease. Journal of Alzheimer's Disease : Jad. 36: 233-8. PMID 23579326 DOI: 10.3233/Jad-122131  0.68
2013 Veyrat-Durebex C, Quirion R, Ferland G, Dumont Y, Gaudreau P. Aging and long-term caloric restriction regulate neuropeptide Y receptor subtype densities in the rat brain. Neuropeptides. 47: 163-9. PMID 23410741 DOI: 10.1016/J.Npep.2013.01.001  0.72
2013 Morales-Medina JC, Juarez I, Venancio-García E, Cabrera SN, Menard C, Yu W, Flores G, Mechawar N, Quirion R. Impaired structural hippocampal plasticity is associated with emotional and memory deficits in the olfactory bulbectomized rat. Neuroscience. 236: 233-43. PMID 23357118 DOI: 10.1016/J.Neuroscience.2013.01.037  1
2013 Ito M, Dumont Y, Quirion R. Mood and memory-associated behaviors in neuropeptide Y5 knockout mice. Neuropeptides. 47: 75-84. PMID 23218957 DOI: 10.1016/J.Npep.2012.10.009  0.56
2013 Wang D, Ruan L, Hong Y, Chabot JG, Quirion R. Involvement of PKA-dependent upregulation of nNOS-CGRP in adrenomedullin-initiated mechanistic pathway underlying CFA-induced response in rats. Experimental Neurology. 239: 111-9. PMID 23063906 DOI: 10.1016/J.Expneurol.2012.10.006  0.68
2012 Morales-Medina JC, Dumont Y, Bonaventure P, Quirion R. Chronic administration of the Y2 receptor antagonist, JNJ-31020028, induced anti-depressant like-behaviors in olfactory bulbectomized rat. Neuropeptides. 46: 329-34. PMID 23103057 DOI: 10.1016/J.Npep.2012.09.009  0.64
2012 Zheng W, Wang H, Zeng Z, Lin J, Little PJ, Srivastava LK, Quirion R. The possible role of the Akt signaling pathway in schizophrenia. Brain Research. 1470: 145-58. PMID 22771711 DOI: 10.1016/j.brainres.2012.06.032  0.72
2012 Morales-Medina JC, Dominguez-Lopez S, Gobbi G, Beck-Sickinger AG, Quirion R. The selective neuropeptide Y Y5 agonist [cPP(1-7),NPY(19-23),Ala31,Aib32,Gln34]hPP differently modulates emotional processes and body weight in the rat. Behavioural Brain Research. 233: 298-304. PMID 22613731 DOI: 10.1016/J.Bbr.2012.05.015  1
2012 Efthimiadi L, Farso M, Quirion R, Krantic S. Cyclin D1 induction preceding neuronal death via the excitotoxic NMDA pathway involves selective stimulation of extrasynaptic NMDA receptors and JNK pathway. Neuro-Degenerative Diseases. 10: 80-91. PMID 22354185 DOI: 10.1159/000335911  0.68
2012 Krantic S, Isorce N, Mechawar N, Davoli MA, Vignault E, Albuquerque M, Chabot JG, Moyse E, Chauvin JP, Aubert I, McLaurin J, Quirion R. Hippocampal GABAergic neurons are susceptible to amyloid-β toxicity in vitro and are decreased in number in the Alzheimer's disease TgCRND8 mouse model. Journal of Alzheimer's Disease : Jad. 29: 293-308. PMID 22232004 DOI: 10.3233/Jad-2011-110830  1
2012 Bringas ME, Morales-Medina JC, Flores-Vivaldo Y, Negrete-Diaz JV, Aguilar-Alonso P, León-Chávez BA, Lazcano-Ortiz Z, Monroy E, Rodríguez-Moreno A, Quirion R, Flores G. Clozapine administration reverses behavioral, neuronal, and nitric oxide disturbances in the neonatal ventral hippocampus rat. Neuropharmacology. 62: 1848-57. PMID 22207157 DOI: 10.1016/J.Neuropharm.2011.12.008  1
2012 Morales-Medina JC, Dumont Y, Benoit CE, Bastianetto S, Flores G, Fournier A, Quirion R. Role of neuropeptide Y Y₁ and Y₂ receptors on behavioral despair in a rat model of depression with co-morbid anxiety. Neuropharmacology. 62: 200-8. PMID 21803058 DOI: 10.1016/J.Neuropharm.2011.06.030  1
2011 Wang Z, Chabot JG, Quirion R. On the possible role of ERK, p38 and CaMKII in the regulation of CGRP expression in morphine-tolerant rats. Molecular Pain. 7: 68. PMID 21933441 DOI: 10.1186/1744-8069-7-68  0.68
2011 Yu W, Mechawar N, Krantic S, Quirion R. α7 Nicotinic receptor activation reduces β-amyloid-induced apoptosis by inhibiting caspase-independent death through phosphatidylinositol 3-kinase signaling. Journal of Neurochemistry. 119: 848-58. PMID 21884524 DOI: 10.1111/J.1471-4159.2011.07466.X  0.68
2011 Farso MC, Krantic S, Rubio M, Sarfati M, Quirion R. The retinoid, 6-[3-adamantyl-4-hydroxyphenyl]-2-napthalene carboxylic acid, controls proliferative, morphological, and inflammatory responses involved in microglial activation without cytotoxic effects. Neuroscience. 192: 172-84. PMID 21749910 DOI: 10.1016/j.neuroscience.2011.06.053  1
2011 Bastianetto S, Krantic S, Chabot JG, Quirion R. Possible involvement of programmed cell death pathways in the neuroprotective action of polyphenols. Current Alzheimer Research. 8: 445-51. PMID 21605053  0.68
2011 Pasic MD, Diamandis EP, McLaurin J, Holtzman DM, Schmitt-Ulms G, Quirion R. Alzheimer disease: advances in pathogenesis, diagnosis, and therapy. Clinical Chemistry. 57: 664-9. PMID 21310870 DOI: 10.1373/Clinchem.2011.161828  1
2011 Benoit CE, Rowe WB, Menard C, Sarret P, Quirion R. Genomic and proteomic strategies to identify novel targets potentially involved in learning and memory. Trends in Pharmacological Sciences. 32: 43-52. PMID 21129790 DOI: 10.1016/J.Tips.2010.10.002  1
2011 Yu W, Gubkina O, Mechawar N, Elwell D, Quirion R, Krantic S. Expression of apoptosis-inducing factor (AIF) in the aged rat brain. Neurobiology of Aging. 32: 179-80. PMID 19251341 DOI: 10.1016/J.Neurobiolaging.2009.01.010  0.68
2011 Tillement P, Hauw J, Dubois B, Racine É, Gzil F, Duckaerts C, Amouyel P, Quirion R, Krantic S, Papadopoulos V, Belleville S, Gauthier S, Michel J, Bergman H, Poncet M. Maladie d’Alzheimer : progrès scientifiques récents et perspectives médicales Bulletin De L Academie Nationale De Medecine. 195: 1743-1747. DOI: 10.1016/S0001-4079(19)31973-9  0.92
2010 Bastianetto S, Dumont Y, Duranton A, Vercauteren F, Breton L, Quirion R. Protective action of resveratrol in human skin: possible involvement of specific receptor binding sites. Plos One. 5: e12935. PMID 20886076 DOI: 10.1371/journal.pone.0012935  0.56
2010 Benoit CE, Bastianetto S, Brouillette J, Tse Y, Boutin JA, Delagrange P, Wong T, Sarret P, Quirion R. Loss of quinone reductase 2 function selectively facilitates learning behaviors. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 30: 12690-700. PMID 20861374 DOI: 10.1523/Jneurosci.2808-10.2010  1
2010 Hong Y, Wang D, Chabot JG, Ma W, Chen P, Quirion R. A role for protein kinase C-dependent upregulation of adrenomedullin in the development of morphine tolerance in male rats. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 30: 12508-16. PMID 20844145 DOI: 10.1523/JNEUROSCI.0306-10.2010  0.68
2010 Wang Z, Ma W, Chabot JG, Quirion R. Morphological evidence for the involvement of microglial p38 activation in CGRP-associated development of morphine antinociceptive tolerance. Peptides. 31: 2179-84. PMID 20804799 DOI: 10.1016/j.peptides.2010.08.020  0.68
2010 Wang Z, Ma W, Chabot JG, Quirion R. Calcitonin gene-related peptide as a regulator of neuronal CaMKII-CREB, microglial p38-NFκB and astroglial ERK-Stat1/3 cascades mediating the development of tolerance to morphine-induced analgesia. Pain. 151: 194-205. PMID 20691540 DOI: 10.1016/J.Pain.2010.07.006  0.68
2010 Bastianetto S, Quirion R. Heme oxygenase 1: another possible target to explain the neuroprotective action of resveratrol, a multifaceted nutrient-based molecule. Experimental Neurology. 225: 237-9. PMID 20603117 DOI: 10.1016/j.expneurol.2010.06.019  0.36
2010 Schorscher-Petcu A, Sotocinal S, Ciura S, Dupré A, Ritchie J, Sorge RE, Crawley JN, Hu SB, Nishimori K, Young LJ, Tribollet E, Quirion R, Mogil JS. Oxytocin-induced analgesia and scratching are mediated by the vasopressin-1A receptor in the mouse. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 30: 8274-84. PMID 20554879 DOI: 10.1523/Jneurosci.1594-10.2010  1
2010 Bastiat G, Plourde F, Motulsky A, Furtos A, Dumont Y, Quirion R, Fuhrmann G, Leroux JC. Tyrosine-based rivastigmine-loaded organogels in the treatment of Alzheimer's disease. Biomaterials. 31: 6031-8. PMID 20472283 DOI: 10.1016/J.Biomaterials.2010.04.009  0.56
2010 Yu W, Mechawar N, Krantic S, Quirion R. Evidence for the involvement of apoptosis-inducing factor-mediated caspase-independent neuronal death in Alzheimer disease. The American Journal of Pathology. 176: 2209-18. PMID 20228227 DOI: 10.2353/Ajpath.2010.090496  0.68
2010 Doggui S, Brouillette J, Chabot JG, Farso M, Quirion R. Possible involvement of transthyretin in hippocampal beta-amyloid burden and learning behaviors in a mouse model of Alzheimer's disease (TgCRND8). Neuro-Degenerative Diseases. 7: 88-95. PMID 20173334 DOI: 10.1159/000285513  0.68
2010 Ma W, Dumont Y, Vercauteren F, Quirion R. Lipopolysaccharide induces calcitonin gene-related peptide in the RAW264.7 macrophage cell line. Immunology. 130: 399-409. PMID 20141542 DOI: 10.1111/j.1365-2567.2009.03239.x  0.56
2010 Mahaut S, Dumont Y, Fournier A, Quirion R, Moyse E. Neuropeptide Y receptor subtypes in the dorsal vagal complex under acute feeding adaptation in the adult rat. Neuropeptides. 44: 77-86. PMID 19880180 DOI: 10.1016/J.Npep.2009.10.001  0.56
2010 Morales-Medina JC, Dumont Y, Quirion R. A possible role of neuropeptide Y in depression and stress. Brain Research. 1314: 194-205. PMID 19782662 DOI: 10.1016/j.brainres.2009.09.077  0.64
2010 Ma W, Chabot JG, Vercauteren F, Quirion R. Injured nerve-derived COX2/PGE2 contributes to the maintenance of neuropathic pain in aged rats. Neurobiology of Aging. 31: 1227-37. PMID 18786748 DOI: 10.1016/j.neurobiolaging.2008.08.002  0.68
2010 Krantic S, Yu W, Hill M, McLaurin J, Quirion R. Early expression of cyclin D1 in vulnerable brain areas of TgCRND8 mouse model of Alzheimer's disease Alzheimers & Dementia. 6. DOI: 10.1016/J.Jalz.2010.05.836  0.68
2010 Ma W, Chabot JG, Schorscher-Petcu A, Hong Y, Wang Z, Quirion R. CGRP and adrenomedullin as pain-related peptides The Calcitonin Gene-Related Peptide Family: Form, Function and Future Perspectives. 151-171. DOI: 10.1007/978-90-481-2909-6_10  1
2009 Hong Y, Liu Y, Chabot JG, Fournier A, Quirion R. Upregulation of adrenomedullin in the spinal cord and dorsal root ganglia in the early phase of CFA-induced inflammation in rats. Pain. 146: 105-13. PMID 19683388 DOI: 10.1016/J.Pain.2009.07.015  0.68
2009 Tong XK, Nicolakakis N, Fernandes P, Ongali B, Brouillette J, Quirion R, Hamel E. Simvastatin improves cerebrovascular function and counters soluble amyloid-beta, inflammation and oxidative stress in aged APP mice. Neurobiology of Disease. 35: 406-14. PMID 19524673 DOI: 10.1016/J.Nbd.2009.06.003  1
2009 Morales-Medina JC, Sanchez F, Flores G, Dumont Y, Quirion R. Morphological reorganization after repeated corticosterone administration in the hippocampus, nucleus accumbens and amygdala in the rat. Journal of Chemical Neuroanatomy. 38: 266-72. PMID 19505571 DOI: 10.1016/J.Jchemneu.2009.05.009  1
2009 Schorscher-Petcu A, Austin JS, Mogil JS, Quirion R. Role of central calcitonin gene-related peptide (CGRP) in locomotor and anxiety- and depression-like behaviors in two mouse strains exhibiting a CGRP-dependent difference in thermal pain sensitivity. Journal of Molecular Neuroscience : Mn. 39: 125-36. PMID 19381879 DOI: 10.1007/s12031-009-9201-z  1
2009 Wang Z, Ma W, Chabot JG, Quirion R. Cell-type specific activation of p38 and ERK mediates calcitonin gene-related peptide involvement in tolerance to morphine-induced analgesia. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 23: 2576-86. PMID 19299480 DOI: 10.1096/fj.08-128348  0.68
2009 Rajah MN, Bastianetto S, Bromley-Brits K, Cools R, D'Esposito M, Grady CL, Poirier J, Quirion R, Raz N, Rogaeva E, Song W, Pruessner J. Biological changes associated with healthy versus pathological aging: a symposium review. Ageing Research Reviews. 8: 140-6. PMID 19274854 DOI: 10.1016/J.Arr.2009.01.003  1
2009 Bastianetto S, Dumont Y, Han Y, Quirion R. Comparative neuroprotective properties of stilbene and catechin analogs: action via a plasma membrane receptor site? Cns Neuroscience & Therapeutics. 15: 76-83. PMID 19228181 DOI: 10.1111/j.1755-5949.2008.00074.x  0.56
2009 Ernst C, Deleva V, Deng X, Sequeira A, Pomarenski A, Klempan T, Ernst N, Quirion R, Gratton A, Szyf M, Turecki G. Alternative splicing, methylation state, and expression profile of tropomyosin-related kinase B in the frontal cortex of suicide completers. Archives of General Psychiatry. 66: 22-32. PMID 19124685 DOI: 10.1001/Archpsyc.66.1.22  1
2008 Morales-Medina JC, Mejorada A, Romero-Curiel A, Aguilar-Alonso P, León-Chávez BA, Gamboa C, Quirion R, Flores G. Neonatal administration of N-omega-nitro-L-arginine induces permanent decrease in NO levels and hyperresponsiveness to locomotor activity by D-amphetamine in postpubertal rats. Neuropharmacology. 55: 1313-20. PMID 18790702 DOI: 10.1016/J.Neuropharm.2008.08.019  1
2008 Bastianetto S, Krantic S, Quirion R. Polyphenols as potential inhibitors of amyloid aggregation and toxicity: possible significance to Alzheimer's disease. Mini Reviews in Medicinal Chemistry. 8: 429-35. PMID 18473932  0.68
2008 Owji AA, Chabot JG, Dumont Y, Quirion R. Adrenomedullin-2/intermedin induces cAMP accumulation in dissociated rat spinal cord cells: evidence for the existence of a distinct class of sites of action. Journal of Molecular Neuroscience : Mn. 35: 355-61. PMID 18418734 DOI: 10.1007/s12031-008-9062-x  0.68
2008 Alquicer G, Morales-Medina JC, Quirion R, Flores G. Postweaning social isolation enhances morphological changes in the neonatal ventral hippocampal lesion rat model of psychosis. Journal of Chemical Neuroanatomy. 35: 179-87. PMID 18061401 DOI: 10.1016/J.Jchemneu.2007.10.001  1
2008 Auld DS, Mennicken F, Day JC, Quirion R. Neurotrophins differentially enhance acetylcholine release, acetylcholine content and choline acetyltransferase activity in basal forebrain neurons: Neurotrophins enhance acetylcholine release Journal of Neurochemistry. 77: 253-262. DOI: 10.1046/J.1471-4159.2001.00234.X  0.4
2007 Dumont Y, Moyse E, Fournier A, Quirion R. Distribution of peripherally injected peptide YY ([125I] PYY (3-36)) and pancreatic polypeptide ([125I] hPP) in the CNS: enrichment in the area postrema. Journal of Molecular Neuroscience : Mn. 33: 294-304. PMID 17952639 DOI: 10.1007/S12031-007-9007-9  0.56
2007 Vercauteren FG, Flores G, Ma W, Chabot JG, Geenen L, Clerens S, Fazel A, Bergeron JJ, Srivastava LK, Arckens L, Quirion R. An organelle proteomic method to study neurotransmission-related proteins, applied to a neurodevelopmental model of schizophrenia. Proteomics. 7: 3569-79. PMID 17907268 DOI: 10.1002/Pmic.200700379  1
2007 Mechawar N, Lacoste B, Yu WF, Srivastava LK, Quirion R. Developmental profile of neuregulin receptor ErbB4 in postnatal rat cerebral cortex and hippocampus. Neuroscience. 148: 126-39. PMID 17630218 DOI: 10.1016/J.Neuroscience.2007.04.066  1
2007 Brouillette J, Young D, During MJ, Quirion R. Hippocampal gene expression profiling reveals the possible involvement of Homer1 and GABA(B) receptors in scopolamine-induced amnesia. Journal of Neurochemistry. 102: 1978-89. PMID 17540011 DOI: 10.1111/j.1471-4159.2007.04666.x  1
2007 Bastianetto S, Brouillette J, Quirion R. Neuroprotective effects of natural products: interaction with intracellular kinases, amyloid peptides and a possible role for transthyretin. Neurochemical Research. 32: 1720-5. PMID 17406978 DOI: 10.1007/s11064-007-9333-x  0.36
2007 Krantic S, Mechawar N, Reix S, Quirion R. Apoptosis-inducing factor: a matter of neuron life and death. Progress in Neurobiology. 81: 179-96. PMID 17267093 DOI: 10.1016/J.Pneurobio.2006.12.002  0.68
2007 Reix S, Mechawar N, Susin SA, Quirion R, Krantic S. Expression of cortical and hippocampal apoptosis-inducing factor (AIF) in aging and Alzheimer's disease. Neurobiology of Aging. 28: 351-6. PMID 16504343 DOI: 10.1016/J.Neurobiolaging.2006.01.003  0.68
2006 Ma W, Chabot JG, Quirion R. A role for adrenomedullin as a pain-related peptide in the rat. Proceedings of the National Academy of Sciences of the United States of America. 103: 16027-32. PMID 17043245 DOI: 10.1073/pnas.0602488103  0.68
2006 Trang T, Ma W, Chabot JG, Quirion R, Jhamandas K. Spinal modulation of calcitonin gene-related peptide by endocannabinoids in the development of opioid physical dependence. Pain. 126: 256-71. PMID 16935424 DOI: 10.1016/J.Pain.2006.07.008  0.68
2006 Rowe WB, Kar S, Meaney MJ, Quirion R. Neurotensin receptor levels as a function of brain aging and cognitive performance in the Morris water maze task in the rat. Peptides. 27: 2415-23. PMID 16872718 DOI: 10.1016/J.Peptides.2006.03.036  1
2006 Seeman P, Schwarz J, Chen JF, Szechtman H, Perreault M, McKnight GS, Roder JC, Quirion R, Boksa P, Srivastava LK, Yanai K, Weinshenker D, Sumiyoshi T. Psychosis pathways converge via D2high dopamine receptors. Synapse (New York, N.Y.). 60: 319-46. PMID 16786561 DOI: 10.1002/Syn.20303  1
2006 Takhshid MA, Poyner DR, Chabot JG, Fournier A, Ma W, Zheng WH, Owji AA, Quirion R. Characterization and effects on cAMP accumulation of adrenomedullin and calcitonin gene-related peptide (CGRP) receptors in dissociated rat spinal cord cell culture. British Journal of Pharmacology. 148: 459-68. PMID 16702994 DOI: 10.1038/Sj.Bjp.0706750  0.68
2006 Carvajal C, Dumont Y, Herzog H, Quirion R. Emotional behavior in aged neuropeptide Y (NPY) Y2 knockout mice. Journal of Molecular Neuroscience : Mn. 28: 239-45. PMID 16691011 DOI: 10.1385/JMN:28:3:239  0.56
2006 Carvajal C, Dumont Y, Quirion R. Neuropeptide y: role in emotion and alcohol dependence. Cns & Neurological Disorders Drug Targets. 5: 181-95. PMID 16611091  0.56
2006 Han YS, Bastianetto S, Dumont Y, Quirion R. Specific plasma membrane binding sites for polyphenols, including resveratrol, in the rat brain. The Journal of Pharmacology and Experimental Therapeutics. 318: 238-45. PMID 16574779 DOI: 10.1124/jpet.106.102319  0.56
2006 Bastianetto S, Danik M, Mennicken F, Williams S, Quirion R. Prototypical antipsychotic drugs protect hippocampal neuronal cultures against cell death induced by growth medium deprivation. Bmc Neuroscience. 7: 28. PMID 16573831 DOI: 10.1186/1471-2202-7-28  0.4
2006 Cassidy CM, Quirion R, Srivastava LK. Blockade of presynaptic voltage-gated calcium channels in the medial prefrontal cortex of neonatal rats leads to post-pubertal alterations in locomotor behavior. Brain Research. 1083: 164-73. PMID 16546143 DOI: 10.1016/j.brainres.2006.01.118  1
2006 Bastianetto S, Yao ZX, Papadopoulos V, Quirion R. Neuroprotective effects of green and black teas and their catechin gallate esters against beta-amyloid-induced toxicity. The European Journal of Neuroscience. 23: 55-64. PMID 16420415 DOI: 10.1111/J.1460-9568.2005.04532.X  0.36
2006 Kar S, Poirier J, Guevara J, Dea D, Hawkes C, Robitaille Y, Quirion R. Cellular distribution of insulin-like growth factor-II/mannose-6-phosphate receptor in normal human brain and its alteration in Alzheimer's disease pathology. Neurobiology of Aging. 27: 199-210. PMID 16399207 DOI: 10.1016/J.Neurobiolaging.2005.03.005  1
2006 Dumont Y, Quirion R. An overview of neuropeptide Y: pharmacology to molecular biology and receptor localization. Exs. 7-33. PMID 16382995  0.56
2005 Illes J, Blakemore C, Hansson MG, Hensch TK, Leshner A, Maestre G, Magistretti P, Quirion R, Strata P. International perspectives on engaging the public in neuroethics. Nature Reviews. Neuroscience. 6: 977-82. PMID 16340957 DOI: 10.1038/Nrn1808  1
2005 Insel TR, Quirion R. Psychiatry as a clinical neuroscience discipline. Jama. 294: 2221-4. PMID 16264165 DOI: 10.1001/Jama.294.17.2221  1
2005 Gan L, Han Y, Bastianetto S, Dumont Y, Unterman TG, Quirion R. FoxO-dependent and -independent mechanisms mediate SirT1 effects on IGFBP-1 gene expression. Biochemical and Biophysical Research Communications. 337: 1092-6. PMID 16236254 DOI: 10.1016/J.Bbrc.2005.09.169  0.56
2005 Dumont Y, Gaudreau P, Mazzuferi M, Langlois D, Chabot JG, Fournier A, Simonato M, Quirion R. BODIPY-conjugated neuropeptide Y ligands: new fluorescent tools to tag Y1, Y2, Y4 and Y5 receptor subtypes. British Journal of Pharmacology. 146: 1069-81. PMID 16231000 DOI: 10.1038/Sj.Bjp.0706425  0.72
2005 Krantic S, Mechawar N, Reix S, Quirion R. Molecular basis of programmed cell death involved in neurodegeneration. Trends in Neurosciences. 28: 670-6. PMID 16216345 DOI: 10.1016/J.Tins.2005.09.011  0.68
2005 Mogil JS, Miermeister F, Seifert F, Strasburg K, Zimmermann K, Reinold H, Austin JS, Bernardini N, Chesler EJ, Hofmann HA, Hordo C, Messlinger K, Nemmani KV, Rankin AL, Ritchie J, ... ... Quirion R, et al. Variable sensitivity to noxious heat is mediated by differential expression of the CGRP gene. Proceedings of the National Academy of Sciences of the United States of America. 102: 12938-43. PMID 16118273 DOI: 10.1073/Pnas.0503264102  1
2005 Redrobe JP, Dumont Y, Fournier A, Baker GB, Quirion R. Role of serotonin (5-HT) in the antidepressant-like properties of neuropeptide Y (NPY) in the mouse forced swim test. Peptides. 26: 1394-400. PMID 16042979 DOI: 10.1016/J.Peptides.2005.03.029  1
2005 Dumont Y, Moyse E, Fournier A, Quirion R. Evidence for the existence of an additional class of neuropeptide Y receptor sites in rat brain. The Journal of Pharmacology and Experimental Therapeutics. 315: 99-108. PMID 15947033 DOI: 10.1124/Jpet.105.089300  0.56
2005 Gan L, Zheng W, Chabot JG, Unterman TG, Quirion R. Nuclear/cytoplasmic shuttling of the transcription factor FoxO1 is regulated by neurotrophic factors. Journal of Neurochemistry. 93: 1209-19. PMID 15934941 DOI: 10.1111/J.1471-4159.2005.03108.X  0.68
2005 Flores G, Alquicer G, Silva-Gómez AB, Zaldivar G, Stewart J, Quirion R, Srivastava LK. Alterations in dendritic morphology of prefrontal cortical and nucleus accumbens neurons in post-pubertal rats after neonatal excitotoxic lesions of the ventral hippocampus. Neuroscience. 133: 463-70. PMID 15878241 DOI: 10.1016/J.Neuroscience.2005.02.021  1
2005 Laplante F, Morin Y, Quirion R, Vaucher E. Acetylcholine release is elicited in the visual cortex, but not in the prefrontal cortex, by patterned visual stimulation: a dual in vivo microdialysis study with functional correlates in the rat brain. Neuroscience. 132: 501-10. PMID 15802200 DOI: 10.1016/J.Neuroscience.2004.11.059  1
2005 Flores G, Silva-Gómez AB, Ibáñez O, Quirion R, Srivastava LK. Comparative behavioral changes in postpubertal rats after neonatal excitotoxic lesions of the ventral hippocampus and the prefrontal cortex. Synapse (New York, N.Y.). 56: 147-53. PMID 15765522 DOI: 10.1002/Syn.20140  1
2005 Seeman P, Weinshenker D, Quirion R, Srivastava LK, Bhardwaj SK, Grandy DK, Premont RT, Sotnikova TD, Boksa P, El-Ghundi M, O'dowd BF, George SR, Perreault ML, Männistö PT, Robinson S, et al. Dopamine supersensitivity correlates with D2High states, implying many paths to psychosis. Proceedings of the National Academy of Sciences of the United States of America. 102: 3513-8. PMID 15716360 DOI: 10.1073/Pnas.0409766102  1
2005 Laplante F, Nakagawasai O, Srivastava LK, Quirion R. Alterations in behavioral responses to a cholinergic agonist in post-pubertal rats with neonatal ventral hippocampal lesions: relationship to changes in muscarinic receptor levels. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 30: 1076-87. PMID 15637638 DOI: 10.1038/Sj.Npp.1300640  0.72
2004 Laplante F, Stevenson CW, Gratton A, Srivastava LK, Quirion R. Effects of neonatal ventral hippocampal lesion in rats on stress-induced acetylcholine release in the prefrontal cortex. Journal of Neurochemistry. 91: 1473-82. PMID 15584923 DOI: 10.1111/J.1471-4159.2004.02831.X  1
2004 Guevara J, Dilhuydy H, Espinosa B, Delacourte A, Quirion R, Mena R, Joanette Y, Zenteno E, Robitaille Y. Coexistence of reactive plasticity and neurodegeneration in Alzheimer diseased brains. Histology and Histopathology. 19: 1075-84. PMID 15375749 DOI: 10.14670/HH-19.1075  1
2004 Bruno MA, Clarke PB, Seltzer A, Quirion R, Burgess K, Cuello AC, Saragovi HU. Long-lasting rescue of age-associated deficits in cognition and the CNS cholinergic phenotype by a partial agonist peptidomimetic ligand of TrkA. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 24: 8009-18. PMID 15371501 DOI: 10.1523/Jneurosci.1508-04.2004  1
2004 Bastianetto S, Quirion R. Natural antioxidants and neurodegenerative diseases. Frontiers in Bioscience : a Journal and Virtual Library. 9: 3447-52. PMID 15353369 DOI: 10.2741/1493  0.36
2004 Dumont Y, Thakur M, Beck-Sickinger A, Fournier A, Quirion R. Characterization of a new neuropeptide Y Y5 agonist radioligand: [125I][cPP(1-7), NPY(19-23), Ala31, Aib32, Gln34]hPP. Neuropeptides. 38: 163-74. PMID 15337369 DOI: 10.1016/J.Npep.2004.04.007  0.56
2004 Carvajal CC, Vercauteren F, Dumont Y, Michalkiewicz M, Quirion R. Aged neuropeptide Y transgenic rats are resistant to acute stress but maintain spatial and non-spatial learning. Behavioural Brain Research. 153: 471-80. PMID 15265645 DOI: 10.1016/J.Bbr.2004.01.004  0.56
2004 Dumont Y, Chabot JG, Quirion R. Receptor autoradiography as mean to explore the possible functional relevance of neuropeptides: focus on new agonists and antagonists to study natriuretic peptides, neuropeptide Y and calcitonin gene-related peptides. Peptides. 25: 365-91. PMID 15134861 DOI: 10.1016/J.Peptides.2004.01.013  0.68
2004 Laplante F, Sibley DR, Quirion R. Reduction in acetylcholine release in the hippocampus of dopamine D5 receptor-deficient mice. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 29: 1620-7. PMID 15100705 DOI: 10.1038/Sj.Npp.1300467  1
2004 Laplante F, Srivastava LK, Quirion R. Alterations in dopaminergic modulation of prefrontal cortical acetylcholine release in post-pubertal rats with neonatal ventral hippocampal lesions. Journal of Neurochemistry. 89: 314-23. PMID 15056275 DOI: 10.1111/J.1471-4159.2004.02351.X  0.72
2004 Han YS, Zheng WH, Bastianetto S, Chabot JG, Quirion R. Neuroprotective effects of resveratrol against beta-amyloid-induced neurotoxicity in rat hippocampal neurons: involvement of protein kinase C. British Journal of Pharmacology. 141: 997-1005. PMID 15028639 DOI: 10.1038/Sj.Bjp.0705688  0.68
2004 Redrobe JP, Dumont Y, Herzog H, Quirion R. Characterization of neuropeptide Y, Y(2) receptor knockout mice in two animal models of learning and memory processing. Journal of Molecular Neuroscience : Mn. 22: 159-66. PMID 14997009 DOI: 10.1385/Jmn:22:3:159  0.56
2004 Bhardwaj SK, Quirion R, Srivastava LK. Post-pubertal adrenergic changes in rats with neonatal lesions of the ventral hippocampus. Neuropharmacology. 46: 85-94. PMID 14654100 DOI: 10.1016/J.Neuropharm.2003.08.001  0.72
2004 Kar S, Quirion R. Amyloid beta peptides and central cholinergic neurons: functional interrelationship and relevance to Alzheimer's disease pathology. Progress in Brain Research. 145: 261-74. PMID 14650921 DOI: 10.1016/S0079-6123(03)45018-8  0.44
2004 Redrobe JP, Carvajal C, Kask A, Dumont Y, Quirion R. Neuropeptide Y and Its Receptor Subtypes in the Central Nervous System: Emphasis on Their Role in Animal Models of Psychiatric Disorders Handbook of Experimental Pharmacology. 162: 101-136. DOI: 10.1007/978-3-642-18764-3_5  0.56
2003 Bhardwaj SK, Beaudry G, Quirion R, Levesque D, Srivastava LK. Neonatal ventral hippocampus lesion leads to reductions in nerve growth factor inducible-B mRNA in the prefrontal cortex and increased amphetamine response in the nucleus accumbens and dorsal striatum. Neuroscience. 122: 669-76. PMID 14622910 DOI: 10.1016/J.Neuroscience.2003.08.016  0.72
2003 Marcotte ER, Srivastava LK, Quirion R. cDNA microarray and proteomic approaches in the study of brain diseases: focus on schizophrenia and Alzheimer's disease. Pharmacology & Therapeutics. 100: 63-74. PMID 14550505 DOI: 10.1016/S0163-7258(03)00086-X  1
2003 Rowe WB, O'Donnell JP, Pearson D, Rose GM, Meaney MJ, Quirion R. Long-term effects of BIBN-99, a selective muscarinic M2 receptor antagonist, on improving spatial memory performance in aged cognitively impaired rats. Behavioural Brain Research. 145: 171-8. PMID 14529815 DOI: 10.1016/S0166-4328(03)00116-5  1
2003 Wood GK, Quirion R, Srivastava LK. Early environment contributes to developmental disruption of MPFC after neonatal ventral hippocampal lesions in rats. Synapse (New York, N.Y.). 50: 223-32. PMID 14515340 DOI: 10.1002/Syn.10265  1
2003 Powell KJ, Quirion R, Jhamandas K. Inhibition of neurokinin-1-substance P receptor and prostanoid activity prevents and reverses the development of morphine tolerance in vivo and the morphine-induced increase in CGRP expression in cultured dorsal root ganglion neurons. The European Journal of Neuroscience. 18: 1572-83. PMID 14511336 DOI: 10.1046/J.1460-9568.2003.02887.X  1
2003 Juaneda C, Dumont Y, Chabot JG, Fournier A, Quirion R. Adrenomedullin receptor binding sites in rat brain and peripheral tissues. European Journal of Pharmacology. 474: 165-74. PMID 12921858 DOI: 10.1016/S0014-2999(03)02042-9  0.68
2003 Ma W, Chabot JG, Powell KJ, Jhamandas K, Dickerson IM, Quirion R. Localization and modulation of calcitonin gene-related peptide-receptor component protein-immunoreactive cells in the rat central and peripheral nervous systems. Neuroscience. 120: 677-94. PMID 12895509 DOI: 10.1016/S0306-4522(03)00159-3  1
2003 Dumont Y, Thakur M, Beck-Sickinger A, Fournier A, Quirion R. Development and characterization of a highly selective neuropeptide Y Y5 receptor agonist radioligand: [125I][hPP1-17, Ala31, Aib32]NPY. British Journal of Pharmacology. 139: 1360-8. PMID 12890716 DOI: 10.1038/Sj.Bjp.0705376  0.56
2003 Degroot A, Kornecook T, Quirion R, DeBow S, Parent MB. Glucose increases hippocampal extracellular acetylcholine levels upon activation of septal GABA receptors. Brain Research. 979: 71-7. PMID 12850573 DOI: 10.1016/S0006-8993(03)02868-3  1
2003 Pheng LH, Dumont Y, Fournier A, Chabot JG, Beaudet A, Quirion R. Agonist- and antagonist-induced sequestration/internalization of neuropeptide Y Y1 receptors in HEK293 cells. British Journal of Pharmacology. 139: 695-704. PMID 12812992 DOI: 10.1038/Sj.Bjp.0705306  1
2003 Redrobe JP, Dumont Y, Herzog H, Quirion R. Neuropeptide Y (NPY) Y2 receptors mediate behaviour in two animal models of anxiety: evidence from Y2 receptor knockout mice. Behavioural Brain Research. 141: 251-5. PMID 12742262 DOI: 10.1016/S0166-4328(02)00374-1  0.56
2003 Rodi D, Mazzuferi M, Bregola G, Dumont Y, Fournier A, Quirion R, Simonato M. Changes in NPY-mediated modulation of hippocampal [3H]D-aspartate outflow in the kindling model of epilepsy. Synapse (New York, N.Y.). 49: 116-24. PMID 12740867 DOI: 10.1002/Syn.10216  0.56
2003 Silva-Gómez AB, Bermudez M, Quirion R, Srivastava LK, Picazo O, Flores G. Comparative behavioral changes between male and female postpubertal rats following neonatal excitotoxic lesions of the ventral hippocampus. Brain Research. 973: 285-92. PMID 12738072 DOI: 10.1016/S0006-8993(03)02537-X  1
2003 Law A, Gauthier S, Quirion R. Alteration of nitric oxide synthase activity in young and aged apolipoprotein E-deficient mice. Neurobiology of Aging. 24: 187-90. PMID 12493565 DOI: 10.1016/S0197-4580(02)00068-4  0.92
2002 Auld DS, Kornecook TJ, Bastianetto S, Quirion R. Alzheimer's disease and the basal forebrain cholinergic system: relations to beta-amyloid peptides, cognition, and treatment strategies. Progress in Neurobiology. 68: 209-45. PMID 12450488 DOI: 10.1016/S0301-0082(02)00079-5  1
2002 Ossipov MH, Zhang ET, Carvajal C, Gardell L, Quirion R, Dumont Y, Lai J, Porreca F. Selective mediation of nerve injury-induced tactile hypersensitivity by neuropeptide Y. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 22: 9858-67. PMID 12427842 DOI: 10.1523/Jneurosci.22-22-09858.2002  1
2002 Seto D, Zheng WH, McNicoll A, Collier B, Quirion R, Kar S. Insulin-like growth factor-I inhibits endogenous acetylcholine release from the rat hippocampal formation: possible involvement of GABA in mediating the effects. Neuroscience. 115: 603-12. PMID 12421625 DOI: 10.1016/S0306-4522(02)00450-5  1
2002 Belanger S, Ma W, Chabot JG, Quirion R. Expression of calcitonin gene-related peptide, substance P and protein kinase C in cultured dorsal root ganglion neurons following chronic exposure to mu, delta and kappa opiates. Neuroscience. 115: 441-53. PMID 12421610 DOI: 10.1016/S0306-4522(02)00452-9  1
2002 Bastianetto S, Quirion R. Natural extracts as possible protective agents of brain aging. Neurobiology of Aging. 23: 891-97. PMID 12392793 DOI: 10.1016/S0197-4580(02)00024-6  0.36
2002 Redrobe JP, Dumont Y, Quirion R. Neuropeptide Y (NPY) and depression: from animal studies to the human condition. Life Sciences. 71: 2921-37. PMID 12384178 DOI: 10.1016/S0024-3205(02)02159-8  0.56
2002 Mollereau C, Mazarguil H, Marcus D, Quelven I, Kotani M, Lannoy V, Dumont Y, Quirion R, Detheux M, Parmentier M, Zajac JM. Pharmacological characterization of human NPFF(1) and NPFF(2) receptors expressed in CHO cells by using NPY Y(1) receptor antagonists. European Journal of Pharmacology. 451: 245-56. PMID 12242085 DOI: 10.1016/S0014-2999(02)02224-0  1
2002 Zheng WH, Kar S, Quirion R. Insulin-like growth factor-1-induced phosphorylation of transcription factor FKHRL1 is mediated by phosphatidylinositol 3-kinase/Akt kinase and role of this pathway in insulin-like growth factor-1-induced survival of cultured hippocampal neurons. Molecular Pharmacology. 62: 225-33. PMID 12130673 DOI: 10.1124/Mol.62.2.225  0.44
2002 Law A, O'Donnell J, Gauthier S, Quirion R. Neuronal and inducible nitric oxide synthase expressions and activities in the hippocampi and cortices of young adult, aged cognitively unimpaired, and impaired Long-Evans rats. Neuroscience. 112: 267-75. PMID 12044445 DOI: 10.1016/S0306-4522(02)00082-9  0.92
2002 Poyner DR, Sexton PM, Marshall I, Smith DM, Quirion R, Born W, Muff R, Fischer JA, Foord SM. International Union of Pharmacology. XXXII. The mammalian calcitonin gene-related peptides, adrenomedullin, amylin, and calcitonin receptors. Pharmacological Reviews. 54: 233-46. PMID 12037140 DOI: 10.1124/Pr.54.2.233  1
2002 Kask A, Harro J, von Hörsten S, Redrobe JP, Dumont Y, Quirion R. The neurocircuitry and receptor subtypes mediating anxiolytic-like effects of neuropeptide Y. Neuroscience and Biobehavioral Reviews. 26: 259-83. PMID 12034130 DOI: 10.1016/S0149-7634(01)00066-5  0.56
2002 Zheng WH, Kar S, Quirion R. FKHRL1 and its homologs are new targets of nerve growth factor Trk receptor signaling. Journal of Neurochemistry. 80: 1049-61. PMID 11953455 DOI: 10.1046/J.0022-3042.2002.00783.X  0.44
2002 Redrobe JP, Dumont Y, Fournier A, Quirion R. The neuropeptide Y (NPY) Y1 receptor subtype mediates NPY-induced antidepressant-like activity in the mouse forced swimming test. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 26: 615-24. PMID 11927186 DOI: 10.1016/S0893-133X(01)00403-1  0.56
2002 Vaucher E, Reymond I, Najaffe R, Kar S, Quirion R, Miller MM, Franklin KB. Estrogen effects on object memory and cholinergic receptors in young and old female mice. Neurobiology of Aging. 23: 87-95. PMID 11755023 DOI: 10.1016/S0197-4580(01)00250-0  0.44
2002 Mennicken F, Chabot JG, Quirion R. Systemic administration of kainic acid in adult rat stimulates expression of the chemokine receptor CCR5 in the forebrain. Glia. 37: 124-38. PMID 11754211 DOI: 10.1002/Glia.10021  0.68
2001 Wood GK, Marcotte ER, Quirion R, Srivastava LK. Strain differences in the behavioural outcome of neonatal ventral hippocampal lesions are determined by the postnatal environment and not genetic factors. The European Journal of Neuroscience. 14: 1030-4. PMID 11595041 DOI: 10.1046/J.0953-816X.2001.01716.X  1
2001 Law A, Gauthier S, Quirion R. Neuroprotective and neurorescuing effects of isoform-specific nitric oxide synthase inhibitors, nitric oxide scavenger, and antioxidant against beta-amyloid toxicity. British Journal of Pharmacology. 133: 1114-24. PMID 11487523 DOI: 10.1038/Sj.Bjp.0704179  0.92
2001 Marcotte ER, Srivastava LK, Quirion R. DNA microarrays in neuropsychopharmacology. Trends in Pharmacological Sciences. 22: 426-36. PMID 11479006 DOI: 10.1016/S0165-6147(00)01741-7  0.72
2001 Juaneda C, Dumont Y, Chabot JG, Quirion R. Autoradiographic distribution of adrenomedullin receptors in the rat brain. European Journal of Pharmacology. 421: R1-2. PMID 11399270 DOI: 10.1016/S0014-2999(01)01021-4  0.68
2001 Auld DS, Mennicken F, Quirion R. Nerve growth factor rapidly induces prolonged acetylcholine release from cultured basal forebrain neurons: differentiation between neuromodulatory and neurotrophic influences. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 21: 3375-82. PMID 11331367 DOI: 10.1523/Jneurosci.21-10-03375.2001  1
2001 Mollereau C, Gouardères C, Dumont Y, Kotani M, Detheux M, Doods H, Parmentier M, Quirion R, Zajac JM. Agonist and antagonist activities on human NPFF(2) receptors of the NPY ligands GR231118 and BIBP3226. British Journal of Pharmacology. 133: 1-4. PMID 11325787 DOI: 10.1038/Sj.Bjp.0704049  0.56
2001 Ma W, Zheng WH, Belanger S, Kar S, Quirion R. Effects of amyloid peptides on cell viability and expression of neuropeptides in cultured rat dorsal root ganglion neurons: a role for free radicals and protein kinase C. The European Journal of Neuroscience. 13: 1125-35. PMID 11285010 DOI: 10.1046/J.1460-9568.2001.01475.X  1
2001 Auld DS, Mennicken F, Day JC, Quirion R. Neurotrophins differentially enhance acetylcholine release, acetylcholine content and choline acetyltransferase activity in basal forebrain neurons. Journal of Neurochemistry. 77: 253-62. PMID 11279281 DOI: 10.1046/J.1471-4159.2001.T01-1-00234.X  1
2001 Law A, Gauthier S, Quirion R. Say NO to Alzheimer's disease: the putative links between nitric oxide and dementia of the Alzheimer's type. Brain Research. Brain Research Reviews. 35: 73-96. PMID 11245887 DOI: 10.1016/S0165-0173(00)00051-5  0.92
2001 Day JC, Kornecook TJ, Quirion R. Application of in vivo microdialysis to the study of cholinergic systems. Methods (San Diego, Calif.). 23: 21-39. PMID 11162147 DOI: 10.1006/Meth.2000.1103  1
2000 Kitaichi K, Chabot JG, Moebius FF, Flandorfer A, Glossmann H, Quirion R. Expression of the purported sigma(1) (sigma(1)) receptor in the mammalian brain and its possible relevance in deficits induced by antagonism of the NMDA receptor complex as revealed using an antisense strategy. Journal of Chemical Neuroanatomy. 20: 375-87. PMID 11207432 DOI: 10.1016/S0891-0618(00)00106-X  1
2000 Zheng WH, Kar S, Doré S, Quirion R. Insulin-like growth factor-1 (IGF-1): a neuroprotective trophic factor acting via the Akt kinase pathway. Journal of Neural Transmission. Supplementum. 261-72. PMID 11205145 DOI: 10.1007/978-3-7091-6301-6_17  0.44
2000 Juaneda C, Dumont Y, Quirion R. The molecular pharmacology of CGRP and related peptide receptor subtypes. Trends in Pharmacological Sciences. 21: 432-8. PMID 11121574 DOI: 10.1016/S0165-6147(00)01555-8  0.56
2000 Thorsell A, Michalkiewicz M, Dumont Y, Quirion R, Caberlotto L, Rimondini R, Mathé AA, Heilig M. Behavioral insensitivity to restraint stress, absent fear suppression of behavior and impaired spatial learning in transgenic rats with hippocampal neuropeptide Y overexpression. Proceedings of the National Academy of Sciences of the United States of America. 97: 12852-7. PMID 11058155 DOI: 10.1073/Pnas.220232997  0.56
2000 Powell KJ, Ma W, Sutak M, Doods H, Quirion R, Jhamandas K. Blockade and reversal of spinal morphine tolerance by peptide and non-peptide calcitonin gene-related peptide receptor antagonists. British Journal of Pharmacology. 131: 875-84. PMID 11053206 DOI: 10.1038/Sj.Bjp.0703655  1
2000 Jafferali S, Dumont Y, Sotty F, Robitaille Y, Quirion R, Kar S. Insulin-like growth factor-I and its receptor in the frontal cortex, hippocampus, and cerebellum of normal human and alzheimer disease brains. Synapse (New York, N.Y.). 38: 450-9. PMID 11044892 DOI: 10.1002/1098-2396(20001215)38:4<450::Aid-Syn10>3.0.Co;2-J  0.56
2000 Law A, Doré S, Blackshaw S, Gauthier S, Quirion R. Alteration of expression levels of neuronal nitric oxide synthase and haem oxygenase-2 messenger RNA in the hippocampi and cortices of young adult and aged cognitively unimpaired and impaired Long-Evans rats. Neuroscience. 100: 769-75. PMID 11036210 DOI: 10.1016/S0306-4522(00)00316-X  1
2000 Bastianetto S, Zheng WH, Quirion R. Neuroprotective abilities of resveratrol and other red wine constituents against nitric oxide-related toxicity in cultured hippocampal neurons. British Journal of Pharmacology. 131: 711-20. PMID 11030720 DOI: 10.1038/Sj.Bjp.0703626  0.36
2000 Ma W, Zheng WH, Kar S, Quirion R. Morphine treatment induced calcitonin gene-related peptide and substance P increases in cultured dorsal root ganglion neurons. Neuroscience. 99: 529-39. PMID 11029544 DOI: 10.1016/S0306-4522(00)00226-8  0.44
2000 Zheng WH, Kar S, Quirion R. Insulin-like growth factor-1-induced phosphorylation of the forkhead family transcription factor FKHRL1 is mediated by Akt kinase in PC12 cells. The Journal of Biological Chemistry. 275: 39152-8. PMID 10995739 DOI: 10.1074/Jbc.M002417200  0.44
2000 Hori T, Subramaniam S, Srivastava LK, Quirion R. Behavioral and neurochemical alterations following repeated phencyclidine administration in rats with neonatal ventral hippocampal lesions. Neuropharmacology. 39: 2478-91. PMID 10974332 DOI: 10.1016/S0028-3908(00)00059-9  0.72
2000 Bastianetto S, Ramassamy C, Doré S, Christen Y, Poirier J, Quirion R. The Ginkgo biloba extract (EGb 761) protects hippocampal neurons against cell death induced by beta-amyloid. The European Journal of Neuroscience. 12: 1882-90. PMID 10886329 DOI: 10.1046/J.1460-9568.2000.00069.X  1
2000 Webster HH, Flores G, Marcotte ER, Cecyre D, Quirion R, Srivastava LK. Olfactory bulbectomy alters NMDA receptor levels in the rat prefrontal cortex. Synapse (New York, N.Y.). 37: 159-62. PMID 10881036 DOI: 10.1002/1098-2396(200008)37:2<159::Aid-Syn9>3.0.Co;2-N  1
2000 Coronas V, Durand M, Chabot JG, Jourdan F, Quirion R. Acetylcholine induces neuritic outgrowth in rat primary olfactory bulb cultures. Neuroscience. 98: 213-9. PMID 10854752 DOI: 10.1016/S0306-4522(00)00143-3  0.68
2000 Bastianetto S, Zheng WH, Quirion R. The Ginkgo biloba extract (EGb 761) protects and rescues hippocampal cells against nitric oxide-induced toxicity: involvement of its flavonoid constituents and protein kinase C. Journal of Neurochemistry. 74: 2268-77. PMID 10820186 DOI: 10.1046/J.1471-4159.2000.0742268.X  0.36
2000 Doré S, Kar S, Zheng WH, Quirion R. Rediscovering good old friend IGF-I in the new millenium: possible usefulness in Alzheimer's disease and stroke. Pharmaceutica Acta Helvetiae. 74: 273-80. PMID 10812969 DOI: 10.1016/S0031-6865(99)00037-0  1
2000 Zheng WH, Kar S, Quirion R. Stimulation of protein kinase C modulates insulin-like growth factor-1-induced akt activation in PC12 cells. The Journal of Biological Chemistry. 275: 13377-85. PMID 10788447 DOI: 10.1074/Jbc.275.18.13377  0.44
2000 Tong Y, Chabot JG, Shen SH, O'Dowd BF, George SR, Quirion R. Ontogenic profile of the expression of the mu opioid receptor gene in the rat telencephalon and diencephalon: an in situ hybridization study. Journal of Chemical Neuroanatomy. 18: 209-22. PMID 10781737 DOI: 10.1016/S0891-0618(00)00043-0  1
2000 Hersi AI, Kitaichi K, Srivastava LK, Gaudreau P, Quirion R. Dopamine D-5 receptor modulates hippocampal acetylcholine release. Brain Research. Molecular Brain Research. 76: 336-40. PMID 10762709 DOI: 10.1016/S0169-328X(00)00015-2  0.72
2000 St-Pierre JA, Nouel D, Dumont Y, Beaudet A, Quirion R. Association of neuropeptide Y Y1 receptors with glutamate-positive and NPY-positive neurons in rat hippocampal cultures. The European Journal of Neuroscience. 12: 1319-30. PMID 10762361 DOI: 10.1046/J.1460-9568.2000.00024.X  1
2000 Dumont Y, Cadieux A, Doods H, Pheng LH, Abounader R, Hamel E, Jacques D, Regoli D, Quirion R. BIIE0246, a potent and highly selective non-peptide neuropeptide Y Y(2) receptor antagonist. British Journal of Pharmacology. 129: 1075-88. PMID 10725255 DOI: 10.1038/Sj.Bjp.0703162  0.56
2000 St-Pierre JA, Nouel D, Dumont Y, Beaudet A, Quirion R. Sub-population of cultured hippocampal astrocytes expresses neuropeptide Y Y(1) receptors. Glia. 30: 82-91. PMID 10696147 DOI: 10.1002/(Sici)1098-1136(200003)30:1<82::Aid-Glia9>3.0.Co;2-8  1
2000 Dumont Y, Quirion R. [(125)I]-GR231118: a high affinity radioligand to investigate neuropeptide Y Y(1) and Y(4) receptors. British Journal of Pharmacology. 129: 37-46. PMID 10694200 DOI: 10.1038/Sj.Bjp.0702983  0.56
2000 Auld DS, Day JC, Mennicken F, Quirion R. Pharmacological characterization of endogenous acetylcholine release from primary septal cultures. The Journal of Pharmacology and Experimental Therapeutics. 292: 692-7. PMID 10640307  1
2000 Jacques D, Dumont Y, rossum DV, Quirion R. Chapter viii calcitonin gene-related peptide (cgrp), amylin and adrenomedullin: anatomical localization and biological functions in the mammalian and human brains Handbook of Chemical Neuroanatomy. 16: 301-374. DOI: 10.1016/S0924-8196(00)80010-X  1
1999 Doré S, Bastianetto S, Kar S, Quirion R. Protective and rescuing abilities of IGF-I and some putative free radical scavengers against beta-amyloid-inducing toxicity in neurons. Annals of the New York Academy of Sciences. 890: 356-64. PMID 10668442 DOI: 10.1111/J.1749-6632.1999.Tb08015.X  0.44
1999 Redrobe JP, Dumont Y, St-Pierre JA, Quirion R. Multiple receptors for neuropeptide Y in the hippocampus: putative roles in seizures and cognition. Brain Research. 848: 153-66. PMID 10612707 DOI: 10.1016/S0006-8993(99)02119-8  0.56
1999 Kitaichi K, Day JC, Quirion R. A novel muscarinic M(4) receptor antagonist provides further evidence of an autoreceptor role for the muscarinic M(2) receptor sub-type. European Journal of Pharmacology. 383: 53-6. PMID 10556681 DOI: 10.1016/S0014-2999(99)00607-X  1
1999 Ramassamy C, Averill D, Beffert U, Bastianetto S, Theroux L, Lussier-Cacan S, Cohn JS, Christen Y, Davignon J, Quirion R, Poirier J. Oxidative damage and protection by antioxidants in the frontal cortex of Alzheimer's disease is related to the apolipoprotein E genotype. Free Radical Biology & Medicine. 27: 544-53. PMID 10490274 DOI: 10.1016/S0891-5849(99)00102-1  1
1999 Raposinho PD, Broqua P, Pierroz DD, Hayward A, Dumont Y, Quirion R, Junien JL, Aubert ML. Evidence that the inhibition of luteinizing hormone secretion exerted by central administration of neuropeptide Y (NPY) in the rat is predominantly mediated by the NPY-Y5 receptor subtype. Endocrinology. 140: 4046-55. PMID 10465275 DOI: 10.1210/Endo.140.9.6985  0.56
1999 Pheng LH, Perron A, Quirion R, Cadieux A, Fauchère JL, Dumont Y, Regoli D. Neuropeptide Y-induced contraction is mediated by neuropeptide Y Y2 and Y4 receptors in the rat colon. European Journal of Pharmacology. 374: 85-91. PMID 10422644 DOI: 10.1016/S0014-2999(99)00296-4  1
1999 Powell KJ, Hosokawa A, Bell A, Sutak M, Milne B, Quirion R, Jhamandas K. Comparative effects of cyclo-oxygenase and nitric oxide synthase inhibition on the development and reversal of spinal opioid tolerance. British Journal of Pharmacology. 127: 631-44. PMID 10401553 DOI: 10.1038/Sj.Bjp.0702587  1
1999 Doré S, Kar S, Chabot JG, Quirion R. Impact of neonatal kainate treatment on hippocampal insulin-like growth factor receptors. Neuroscience. 91: 1035-43. PMID 10391481 DOI: 10.1016/S0306-4522(98)00646-0  0.68
1999 Flores G, Liang JJ, Sierra A, Martínez-Fong D, Quirion R, Aceves J, Srivastava LK. Expression of dopamine receptors in the subthalamic nucleus of the rat: characterization using reverse transcriptase-polymerase chain reaction and autoradiography. Neuroscience. 91: 549-56. PMID 10366012 DOI: 10.1016/S0306-4522(98)00633-2  1
1999 Mennicken F, Maki R, de Souza EB, Quirion R. Chemokines and chemokine receptors in the CNS: a possible role in neuroinflammation and patterning. Trends in Pharmacological Sciences. 20: 73-8. PMID 10101968 DOI: 10.1016/S0165-6147(99)01308-5  0.4
1999 Kitaichi K, Hori T, Srivastava LK, Quirion R. Antisense oligodeoxynucleotides against the muscarinic m2, but not m4, receptor supports its role as autoreceptors in the rat hippocampus. Brain Research. Molecular Brain Research. 67: 98-106. PMID 10101237 DOI: 10.1016/S0169-328X(99)00047-9  0.72
1999 Bastianetto S, Ramassamy C, Poirier J, Quirion R. Dehydroepiandrosterone (DHEA) protects hippocampal cells from oxidative stress-induced damage. Brain Research. Molecular Brain Research. 66: 35-41. PMID 10095075 DOI: 10.1016/S0169-328X(99)00002-9  1
1998 Durand M, Coronas V, Jourdan F, Quirion R. Developmental and aging aspects of the cholinergic innervation of the olfactory bulb. International Journal of Developmental Neuroscience : the Official Journal of the International Society For Developmental Neuroscience. 16: 777-85. PMID 10198824 DOI: 10.1016/S0736-5748(98)00087-2  0.6
1998 Dumont Y, Jacques D, Bouchard P, Quirion R. Species differences in the expression and distribution of the neuropeptide Y Y1, Y2, Y4, and Y5 receptors in rodents, guinea pig, and primates brains. The Journal of Comparative Neurology. 402: 372-84. PMID 9853905 DOI: 10.1002/(Sici)1096-9861(19981221)402:3<372::Aid-Cne6>3.0.Co;2-2  1
1998 Flores G, Wood GK, Barbeau D, Quirion R, Srivastava LK. Lewis and Fischer rats: a comparison of dopamine transporter and receptors levels. Brain Research. 814: 34-40. PMID 9838033 DOI: 10.1016/S0006-8993(98)01011-7  1
1998 Jacques D, Tong Y, Shen SH, Quirion R. Discrete distribution of the neuropeptide Y Y5 receptor gene in the human brain: an in situ hybridization study. Brain Research. Molecular Brain Research. 61: 100-7. PMID 9795164 DOI: 10.1016/S0169-328X(98)00208-3  0.32
1998 Kar S, Issa AM, Seto D, Auld DS, Collier B, Quirion R. Amyloid beta-peptide inhibits high-affinity choline uptake and acetylcholine release in rat hippocampal slices. Journal of Neurochemistry. 70: 2179-87. PMID 9572306 DOI: 10.1046/J.1471-4159.1998.70052179.X  1
1998 Wood GK, Tomasiewicz H, Rutishauser U, Magnuson T, Quirion R, Rochford J, Srivastava LK. NCAM-180 knockout mice display increased lateral ventricle size and reduced prepulse inhibition of startle. Neuroreport. 9: 461-6. PMID 9512390 DOI: 10.1097/00001756-199802160-00019  1
1998 St-Pierre JA, Dumont Y, Nouel D, Herzog H, Hamel E, Quirion R. Preferential expression of the neuropeptide Y Y1 over the Y2 receptor subtype in cultured hippocampal neurons and cloning of the rat Y2 receptor. British Journal of Pharmacology. 123: 183-94. PMID 9489605 DOI: 10.1038/Sj.Bjp.0701589  0.56
1998 Thiffault C, Quirion R, Poirier J. Effect of the MAO-B inhibitor, MDL72974, on superoxide dismutase activity and lipid peroxidation levels in the mouse brain. Synapse (New York, N.Y.). 28: 208-11. PMID 9488505 DOI: 10.1002/(Sici)1098-2396(199803)28:3<208::Aid-Syn3>3.0.Co;2-E  1
1998 Rowe WB, Spreekmeester E, Meaney MJ, Quirion R, Rochford J. Reactivity to novelty in cognitively-impaired and cognitively-unimpaired aged rats and young rats. Neuroscience. 83: 669-80. PMID 9483551 DOI: 10.1016/S0306-4522(97)00464-8  1
1998 Auld DS, Kar S, Quirion R. Beta-amyloid peptides as direct cholinergic neuromodulators: a missing link? Trends in Neurosciences. 21: 43-9. PMID 9464686 DOI: 10.1016/S0166-2236(97)01144-2  1
1998 Doré S, Kar S, Auld D, Chabot J, Quirion R. Autoradiographic Localization of Growth Factor Receptors in Neuronal Tissues Current Protocols in Pharmacology. 3. DOI: 10.1002/0471141755.Ph0802S03  0.48
1997 Bastianetto S, Quirion R. Any facts behind the DHEA hype? Trends in Pharmacological Sciences. 18: 447-9. PMID 9458690 DOI: 10.1016/S0165-6147(97)01134-6  0.36
1997 Wood GK, Liang JJ, Flores G, Ahmad S, Quirion R, Srivastava LK. Cloning and in situ hybridization analysis of the expression of polysialyltransferase mRNA in the developing and adult rat brain. Brain Research. Molecular Brain Research. 51: 69-81. PMID 9427508 DOI: 10.1016/S0169-328X(97)00209-X  1
1997 Bouchard P, Maurice T, St-Pierre S, Privat A, Quirion R. Neuropeptide Y and the calcitonin gene-related peptide attenuate learning impairments induced by MK-801 via a sigma receptor-related mechanism. The European Journal of Neuroscience. 9: 2142-51. PMID 9421174 DOI: 10.1111/J.1460-9568.1997.Tb01381.X  0.64
1997 Kar S, Seto D, Doré S, Hanisch U, Quirion R. Insulin-like growth factors-I and -II differentially regulate endogenous acetylcholine release from the rat hippocampal formation. Proceedings of the National Academy of Sciences of the United States of America. 94: 14054-9. PMID 9391151 DOI: 10.1073/Pnas.94.25.14054  0.44
1997 Thiffault C, Quirion R, Poirier J. The effect of L-deprenyl, D-deprenyl and MDL72974 on mitochondrial respiration: a possible mechanism leading to an adaptive increase in superoxide dismutase activity. Brain Research. Molecular Brain Research. 49: 127-36. PMID 9387872 DOI: 10.1016/S0169-328X(97)00135-6  1
1997 Tong Y, Dumont Y, Shen SH, Quirion R. Comparative developmental profile of the neuropeptide Y Y1 receptor gene and protein in the rat brain. Brain Research. Molecular Brain Research. 48: 323-32. PMID 9332730 DOI: 10.1016/S0169-328X(97)00107-1  0.56
1997 Kar S, Seto D, Doré S, Chabot JG, Quirion R. Systemic administration of kainic acid induces selective time dependent decrease in [125I]insulin-like growth factor I, [125I]insulin-like growth factor II and [125I]insulin receptor binding sites in adult rat hippocampal formation. Neuroscience. 80: 1041-55. PMID 9284059 DOI: 10.1016/S0306-4522(97)00185-1  0.68
1997 Doré S, Kar S, Rowe W, Quirion R. Distribution and levels of [125I]IGF-I, [125I]IGF-II and [125I]insulin receptor binding sites in the hippocampus of aged memory-unimpaired and -impaired rats. Neuroscience. 80: 1033-40. PMID 9284058 DOI: 10.1016/S0306-4522(97)00154-1  0.44
1997 Rowe WB, Nicot A, Sharma S, Gully D, Walker CD, Rostène WH, Meaney MJ, Quirion R. Central administration of the neurotensin receptor antagonist, SR48692, modulates diurnal and stress-related hypothalamic-pituitary-adrenal activity. Neuroendocrinology. 66: 75-85. PMID 9263204 DOI: 10.1159/000127223  1
1997 Plourde V, St-Pierre S, Quirion R. Calcitonin gene-related peptide in viscerosensitive response to colorectal distension in rats. The American Journal of Physiology. 273: G191-6. PMID 9252526 DOI: 10.1152/AJPGI.1997.273.1.G191  0.64
1997 Doré S, Kar S, Quirion R. Rediscovering an old friend, IGF-I: potential use in the treatment of neurodegenerative diseases. Trends in Neurosciences. 20: 326-31. PMID 9246719 DOI: 10.1016/S0166-2236(96)01036-3  0.44
1997 Mufson EJ, Lavine N, Jaffar S, Kordower JH, Quirion R, Saragovi HU. Reduction in p140-TrkA receptor protein within the nucleus basalis and cortex in Alzheimer's disease. Experimental Neurology. 146: 91-103. PMID 9225742 DOI: 10.1006/Exnr.1997.6504  1
1997 Hanisch UK, Neuhaus J, Rowe W, Van Rossum D, Möller T, Kettenmann H, Quirion R. Neurotoxic consequences of central long-term administration of interleukin-2 in rats. Neuroscience. 79: 799-818. PMID 9219943 DOI: 10.1016/S0306-4522(97)00040-7  1
1997 Pheng LH, Fournier A, Dumont Y, Quirion R, Regoli D. The dog saphenous vein: a sensitive and selective preparation for the Y2 receptor of neuropeptide Y. European Journal of Pharmacology. 327: 163-7. PMID 9200555 DOI: 10.1016/S0014-2999(97)89656-2  0.56
1997 Jacques D, Dumont Y, Fournier A, Quirion R. Characterization of neuropeptide Y receptor subtypes in the normal human brain, including the hypothalamus. Neuroscience. 79: 129-48. PMID 9178870 DOI: 10.1016/S0306-4522(96)00639-2  1
1997 Doré S, Kar S, Quirion R. Presence and differential internalization of two distinct insulin-like growth factor receptors in rat hippocampal neurons. Neuroscience. 78: 373-83. PMID 9145794 DOI: 10.1016/S0306-4522(96)00594-5  0.44
1997 Seto D, Kar S, Quirion R. Evidence for direct and indirect mechanisms in the potent modulatory action of interleukin-2 on the release of acetylcholine in rat hippocampal slices. British Journal of Pharmacology. 120: 1151-7. PMID 9134229 DOI: 10.1038/Sj.Bjp.0701002  0.44
1997 Mennicken F, Quirion R. Interleukin-2 increases choline acetyltransferase activity in septal-cell cultures. Synapse (New York, N.Y.). 26: 175-83. PMID 9131776 DOI: 10.1002/(SICI)1098-2396(199706)26:2<175::AID-SYN8>3.0.CO;2-5  0.4
1997 Doré S, Kar S, Quirion R. Insulin-like growth factor I protects and rescues hippocampal neurons against beta-amyloid- and human amylin-induced toxicity. Proceedings of the National Academy of Sciences of the United States of America. 94: 4772-7. PMID 9114067 DOI: 10.1073/Pnas.94.9.4772  0.44
1997 Thiffault C, Lamarre-Théroux L, Quirion R, Poirier J. L-Deprenyl and MDL72974 do not improve the recovery of dopaminergic cells following systemic administration of MPTP in mouse. Brain Research. Molecular Brain Research. 44: 238-44. PMID 9073165 DOI: 10.1016/S0169-328X(96)00203-3  1
1997 Nouel D, Faure MP, St Pierre JA, Alonso R, Quirion R, Beaudet A. Differential binding profile and internalization process of neurotensin via neuronal and glial receptors. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 17: 1795-803. PMID 9030638 DOI: 10.1523/Jneurosci.17-05-01795.1997  1
1997 Doré S, Kar S, Quirion R. Emploi thérapeutique de l'IGF-I dans le traitement de maladies neurodégénératives. MéDecine/Sciences. 13: 557. DOI: 10.4267/10608/412  0.48
1996 Hanisch UK, Rowe W, van Rossum D, Meaney MJ, Quirion R. Phasic hyperactivity of the HPA axis resulting from chronic central IL-2 administration. Neuroreport. 7: 2883-8. PMID 9116202 DOI: 10.1097/00001756-199611250-00015  0.44
1996 Trinh T, van Dumont Y, Quirion R. High levels of specific neuropeptide Y/pancreatic polypeptide receptors in the rat hypothalamus and brainstem. European Journal of Pharmacology. 318: R1-3. PMID 9007534 DOI: 10.1016/S0014-2999(96)00863-1  1
1996 Chabot JG, Kar S, Quirion R. Autoradiographical and immunohistochemical analysis of receptor localization in the central nervous system. The Histochemical Journal. 28: 729-45. PMID 8968726 DOI: 10.1007/Bf02272147  0.68
1996 Flores G, Wood GK, Liang JJ, Quirion R, Srivastava LK. Enhanced amphetamine sensitivity and increased expression of dopamine D2 receptors in postpubertal rats after neonatal excitotoxic lesions of the medial prefrontal cortex. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 16: 7366-75. PMID 8929443 DOI: 10.1523/Jneurosci.16-22-07366.1996  1
1996 Le Jeune H, Aubert I, Jourdan F, Quirion R. Developmental profiles of various cholinergic markers in the rat main olfactory bulb using quantitative autoradiography. The Journal of Comparative Neurology. 373: 433-50. PMID 8889937 DOI: 10.1002/(Sici)1096-9861(19960923)373:3<433::Aid-Cne8>3.0.Co;2-3  1
1996 Doré S, Krieger C, Kar S, Quirion R. Distribution and levels of insulin-like growth factor (IGF-I and IGF-II) and insulin receptor binding sites in the spinal cords of amyotrophic lateral sclerosis (ALS) patients. Brain Research. Molecular Brain Research. 41: 128-33. PMID 8883943 DOI: 10.1016/0169-328X(96)00081-2  1
1996 Le Jeune H, Cécyre D, Rowe W, Meaney MJ, Quirion R. Ionotropic glutamate receptor subtypes in the aged memory-impaired and unimpaired Long-Evans rat. Neuroscience. 74: 349-63. PMID 8865188 DOI: 10.1016/0306-4522(96)00213-8  0.6
1996 Hersi AI, Rowe W, Gaudreau P, Quirion R. Dopamine D1 receptor ligands modulate cognitive performance and hippocampal acetylcholine release in memory-impaired aged rats. Neuroscience. 69: 1067-74. PMID 8848095 DOI: 10.1016/0306-4522(95)00319-E  0.36
1996 Jacques D, Tong Y, Dumont Y, Shen SH, Quirion R. Expression of the neuropeptide Y Y1 receptor mRNA in the human brain: an in situ hybridization study. Neuroreport. 7: 1053-6. PMID 8804050 DOI: 10.1097/00001756-199604100-00020  0.56
1996 LeSauteur L, Maliartchouk S, Le Jeune H, Quirion R, Saragovi HU. Potent human p140-TrkA agonists derived from an anti-receptor monoclonal antibody. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 16: 1308-16. PMID 8778282 DOI: 10.1523/Jneurosci.16-04-01308.1996  1
1996 Dumont Y, St-Pierre JA, Quirion R. Comparative autoradiographic distribution of neuropeptide Y Y1 receptors visualized with the Y1 receptor agonist [125I][Leu31,Pro34]PYY and the non-peptide antagonist [3H]BIBP3226. Neuroreport. 7: 901-4. PMID 8724669 DOI: 10.1097/00001756-199603220-00013  0.56
1996 Aubert I, Cécyre D, Gauthier S, Quirion R. Comparative ontogenic profile of cholinergic markers, including nicotinic and muscarinic receptors, in the rat brain. The Journal of Comparative Neurology. 369: 31-55. PMID 8723701 DOI: 10.1002/(Sici)1096-9861(19960520)369:1<31::Aid-Cne3>3.0.Co;2-L  1
1996 Flores G, Barbeau D, Quirion R, Srivastava LK. Decreased binding of dopamine D3 receptors in limbic subregions after neonatal bilateral lesion of rat hippocampus. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 16: 2020-6. PMID 8604046 DOI: 10.1523/Jneurosci.16-06-02020.1996  1
1995 Poirier J, Delisle MC, Quirion R, Aubert I, Farlow M, Lahiri D, Hui S, Bertrand P, Nalbantoglu J, Gilfix BM, Gauthier S. Apolipoprotein E4 allele as a predictor of cholinergic deficits and treatment outcome in Alzheimer disease. Proceedings of the National Academy of Sciences of the United States of America. 92: 12260-4. PMID 8618881 DOI: 10.1073/Pnas.92.26.12260  1
1995 Le Jeune H, Aubert I, Jourdan F, Quirion R. Comparative laminar distribution of various autoradiographic cholinergic markers in adult rat main olfactory bulb. Journal of Chemical Neuroanatomy. 9: 99-112. PMID 8561953 DOI: 10.1016/0891-0618(95)00070-N  1
1995 Bouchard P, Monnet F, Bergeron R, Roman F, Junien J‐, de Montigny C, Debonnel G, Quirion R. In Vivo Modulation of Sigma Receptor Sites by Calcitonin Gene‐related Peptide in the Mouse and Rat Hippocampal Formation: Radioligand Binding and Electrophysiological Studies European Journal of Neuroscience. 7: 1952-1962. PMID 8528471 DOI: 10.1111/J.1460-9568.1995.Tb00718.X  1
1995 Parent A, Rowe W, Meaney MJ, Quirion R. Increased production of inositol phosphates and diacylglycerol in aged cognitively impaired rats after stimulation of muscarinic, metabotropic-glutamate and endothelin receptors. The Journal of Pharmacology and Experimental Therapeutics. 272: 1110-6. PMID 7891323  1
1995 Quirion R, Wilson A, Rowe W, Aubert I, Richard J, Doods H, Parent A, White N, Meaney MJ. Facilitation of acetylcholine release and cognitive performance by an M(2)-muscarinic receptor antagonist in aged memory-impaired. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 15: 1455-62. PMID 7869110 DOI: 10.1523/Jneurosci.15-02-01455.1995  1
1995 Kar S, Quirion R. Neuropeptide receptors in developing and adult rat spinal cord: An in vitro quantitative autoradiography study of calcitonin gene-related peptide, neurokinins, μ-opioid, galanin, somatostatin, neurotensin and vasoactive intestinal polypeptide receptors Journal of Comparative Neurology. 354: 253-281. PMID 7782502 DOI: 10.1002/Cne.903540208  1
1995 Rowe W, Viau V, Meaney MJ, Quirion R. Stimulation of CRH-mediated ACTH secretion by central administration of neurotensin: evidence for the participation of the paraventricular nucleus. Journal of Neuroendocrinology. 7: 109-17. PMID 7767323 DOI: 10.1111/J.1365-2826.1995.Tb00673.X  1
1995 Yashpal K, Pitcher GM, Parent A, Quirion R, Coderre TJ. Noxious thermal and chemical stimulation induce increases in 3H-phorbol 12,13-dibutyrate binding in spinal cord dorsal horn as well as persistent pain and hyperalgesia, which is reduced by inhibition of protein kinase C. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 15: 3263-72. PMID 7751909 DOI: 10.1523/Jneurosci.15-05-03263.1995  1
1995 Barbeau D, Liang JJ, Robitaille Y, Quirion R, Srivastava LK. Decreased expression of the embryonic form of the neural cell adhesion molecule in schizophrenic brains Proceedings of the National Academy of Sciences of the United States of America. 92: 2785-2789. PMID 7708724 DOI: 10.1073/Pnas.92.7.2785  1
1995 Aubert I, Rowe W, Meaney MJ, Gauthier S, Quirion R. Cholinergic markers in aged cognitively impaired Long-Evans rats. Neuroscience. 67: 277-92. PMID 7675169 DOI: 10.1016/0306-4522(95)00056-O  1
1995 Jacques D, Cadieux A, Dumont Y, Quirion R. Apparent affinity and potency of BIBP3226, a non-peptide neuropeptide Y receptor antagonist, on purported neuropeptide Y Y1, Y2 and Y3 receptors European Journal of Pharmacology. 278. PMID 7664808 DOI: 10.1016/0014-2999(95)00179-O  1
1995 Krieger C, Jacques D, Parent A, Quirion R. [3H]phorbol 12,13-dibutyrate/PKC binding in thoracic spinal cord: no change in amyotrophic lateral sclerosis. Neuroreport. 6: 1381-4. PMID 7488729 DOI: 10.1097/00001756-199507100-00005  1
1994 Aubert I, Poirier J, Gauthier S, Quirion R. Multiple cholinergic markers are unexpectedly not altered in the rat dentate gyrus following entorhinal cortex lesions. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 14: 2476-84. PMID 8182423 DOI: 10.1523/Jneurosci.14-05-02476.1994  1
1994 Parent A, Quirion R. Differential localization and pH dependency of phosphoinositide 1,4,5-IP3, 1,3,4,5-IP4 and IP6 receptors in rat and human brains. The European Journal of Neuroscience. 6: 67-74. PMID 8130933 DOI: 10.1111/J.1460-9568.1994.Tb00248.X  1
1994 Nicot A, Bérod A, Gully D, Rowe W, Quirion R, de Kloet ER, Rostène W. Blockade of neurotensin binding in the rat hypothalamus and of the central action of neurotensin on the hypothalamic-pituitary-adrenal axis with non-peptide receptor antagonists. Neuroendocrinology. 59: 572-8. PMID 8084381 DOI: 10.1159/000126707  1
1994 Kar S, Quirion R, Parent A. An interaction between inositol hexakisphosphate (IP6) and insulin-like growth factor II receptor binding sites in the rat brain. Neuroreport. 5: 625-8. PMID 8025258  1
1994 Hanisch UK, Rowe W, Sharma S, Meaney MJ, Quirion R. Hypothalamic-pituitary-adrenal activity during chronic central administration of interleukin-2. Endocrinology. 135: 2465-72. PMID 7988433 DOI: 10.1210/Endo.135.6.7988433  0.44
1994 Parent A, Poirier J, Baccichet A, Quirion R. Regulation of 1,4,5-IP3, 1,3,4,5-IP4 and IP6 binding sites following entorhinal cortex lesions in rat brain. Neuroscience. 61: 565-73. PMID 7969930 DOI: 10.1016/0306-4522(94)90434-0  1
1994 Zupanc GK, Cécyre D, Maler L, Zupanc MM, Quirion R. The distribution of somatostatin binding sites in the brain of gymnotiform fish, Apteronotus leptorhynchus. Journal of Chemical Neuroanatomy. 7: 49-63. PMID 7802970 DOI: 10.1016/0891-0618(94)90007-8  1
1994 Alonso R, Poirier J, O'Donnell D, Buisson N, Diorio J, Boksa P, Quirion R. Statin, a marker of cell cycle arrest, is overexpressed during the early phase of delayed NMDA toxicity in hippocampal cell cultures. Molecular and Cellular Neurosciences. 5: 530-9. PMID 7704426 DOI: 10.1006/Mcne.1994.1065  1
1994 Kar S, Quirion R. Galanin receptor binding sites in adult rat spinal cord respond differentially to neonatal capsaicin, dorsal rhizotomy and peripheral axotomy European Journal of Neuroscience. 6: 1917-1921. PMID 7704302 DOI: 10.1111/J.1460-9568.1994.Tb00583.X  1
1994 Chaudieu I, St-Pierre JA, Quirion R, Boksa P. GABAA receptor-mediated inhibition of N-methyl-D-aspartate-evoked [3H]dopamine release from mesencephalic cell cultures. European Journal of Pharmacology. 264: 361-9. PMID 7698177 DOI: 10.1016/0014-2999(94)00492-7  1
1994 Yashpal K, Kar S, Quirion R, Hui-Chan CW, Henry JL. Noxious stimulation decreases substance P binding in rat spinal dorsal horn: competition by endogenous ligand? Neuroreport. 5: 2101-4. PMID 7532453 DOI: 10.1097/00001756-199410270-00028  1
1994 Weld MM, Kar S, Maler L, Quirion R. The distribution of tachykinin binding sites in the brain of an electric fish (Apteronotus leptorhynchus). Journal of Chemical Neuroanatomy. 7: 123-39. PMID 7531453 DOI: 10.1016/0891-0618(94)90024-8  1
1994 Nicot A, Bérod A, Gully D, Rowe W, Quirion R, Kloet ERd, Rostène W, Sumova A, Ebling FJP, Maywood ES, Herbert J, Hastings MH, Harris KH, Linetsky E, Jhamandas JH, et al. Subject Index Vol. 59, 1994 Neuroendocrinology. 59: 612-613. DOI: 10.1159/000126712  0.44
1994 Nicot A, Bérod A, Gully D, Rowe W, Quirion R, Kloet ERd, Rostène W, Sumova A, Ebling FJP, Maywood ES, Herbert J, Hastings MH, Harris KH, Linetsky E, Jhamandas JH, et al. Contents, Vol. 59, 1994 Neuroendocrinology. 59. DOI: 10.1159/000126699  0.44
1993 Murase K, Nabeshima T, Robitaille Y, Quirion R, Ogawa M, Hayashi K. NGF level of is not decreased in the serum, brain-spinal fluid, hippocampus, or parietal cortex of individuals with Alzheimer's disease. Biochemical and Biophysical Research Communications. 193: 198-203. PMID 8503908 DOI: 10.1006/BBRC.1993.1609  0.48
1993 Parent A, Dea D, Quirion R, Poirier J. [3H]phorbol ester binding sites and neuronal plasticity in the hippocampus following entorhinal cortex lesions. Brain Research. 607: 23-32. PMID 8481798 DOI: 10.1016/0006-8993(93)91485-B  1
1993 Doods HN, Quirion R, Mihm G, Engel W, Rudolf K, Entzeroth M, Schiavi GB, Ladinsky H, Bechtel WD, Ensinger HA. Therapeutic potential of CNS-active M2 antagonists: novel structures and pharmacology. Life Sciences. 52: 497-503. PMID 8441330 DOI: 10.1016/0024-3205(93)90307-O  1
1993 Prasad Sen A, Boksa P, Quirion R. Brain calcium channel related dihydropyridine and phenylalkylamine binding sites in Alzheimer's, Parkinson's and Huntington's diseases Brain Research. 611: 216-221. PMID 8392892 DOI: 10.1016/0006-8993(93)90505-H  1
1993 Alonso R, Chaudieu I, Diorio J, Krishnamurthy A, Quirion R, Boksa P. Interleukin-2 modulates evoked release of [3H]dopamine in rat cultured mesencephalic cells. Journal of Neurochemistry. 61: 1284-90. PMID 8376986 DOI: 10.1111/J.1471-4159.1993.Tb13620.X  1
1993 Allaoua H, Chaudieu I, Alonso R, Quirion R, Boksa P. Muscarinic potentiation of excitatory amino acid-evoked dopamine release in mesencephalic cells: Specificity for the NMDA response and role of intracellular messengers Synapse. 15: 39-47. PMID 8310424 DOI: 10.1002/Syn.890150105  1
1993 Quirion R, Aubert I, Araujo DM, Hersi A, Gaudreau P. Autoradiographic distribution of putative muscarinic receptor sub-types in mammalian brain. Progress in Brain Research. 98: 85-93. PMID 8248541 DOI: 10.1016/S0079-6123(08)62384-5  1
1993 Watling KJ, Guard S, Krause JE, Takeda Y, Quirion R, Zarnegar R, Pain D, Franks R. On the presence of NK2 receptor subtypes in peripheral and central tissues. Regulatory Peptides. 46: 311-3. PMID 8210495 DOI: 10.1016/0167-0115(93)90070-O  1
1993 Wood JA, Wood PL, Ryan R, Graff-Radford NR, Pilapil C, Robitaille Y, Quirion R. Cytokine indices in Alzheimer's temporal cortex: no changes in mature IL-1 beta or IL-1RA but increases in the associated acute phase proteins IL-6, alpha 2-macroglobulin and C-reactive protein. Brain Research. 629: 245-52. PMID 7509248 DOI: 10.1016/0006-8993(93)91327-O  0.48
1993 Seto D, Hanisch U, Villemain F, Beaudet A, Quirion R. Anatomical and Functional Approaches to Study of Interleukin 2 and Its Receptors in Brain Methods in Neurosciences. 16: 173-184. DOI: 10.1016/B978-0-12-185281-8.50016-8  0.32
1992 Aubert I, Araujo DM, Cécyre D, Robitaille Y, Gauthier S, Quirion R. Comparative alterations of nicotinic and muscarinic binding sites in Alzheimer's and Parkinson's diseases. Journal of Neurochemistry. 58: 529-41. PMID 1729398 DOI: 10.1111/J.1471-4159.1992.Tb09752.X  1
1992 Aubert I, Cécyre D, Gauthier S, Quirion R. Characterization and autoradiographic distribution of [3H]AF-DX 384 binding to putative muscarinic M2 receptors in the rat brain. European Journal of Pharmacology. 217: 173-84. PMID 1425938 DOI: 10.1016/0014-2999(92)90843-S  1
1992 Chaudieu I, Alonso R, Mount H, Quirion R, Boksa P. Effects of L- and N-type Ca2+ channel antagonists on excitatory amino acid-evoked dopamine release European Journal of Pharmacology. 220: 203-209. PMID 1385182 DOI: 10.1016/0014-2999(92)90749-T  1
1992 Krantic S, Robitaille Y, Quirion R. Deficits in the somatostatin SS1 receptor sub-type in frontal and temporal cortices in Alzheimer's disease. Brain Research. 573: 299-304. PMID 1354549 DOI: 10.1016/0006-8993(92)90776-6  0.68
1992 Rowe W, Viau V, Meaney MJ, Quirion R. Central administration of neurotensin stimulates hypothalamic-pituitary-adrenal activity. The paraventricular CRF neuron as a critical site of action. Annals of the New York Academy of Sciences. 668: 365-7. PMID 1334391 DOI: 10.1111/J.1749-6632.1992.Tb27378.X  1
1992 Kar S, Quirion R. Quantitative autoradiographic localization of [125I] neuropeptide Y receptor binding sites in rat spinal cord and the effects of neonatal capsaicin, dorsal rhizotomy and peripheral axotomy Brain Research. 574: 333-337. PMID 1322224 DOI: 10.1016/0006-8993(92)90836-X  1
1992 Allaoua H, Chaudieu I, Boksa P, Perry TL, Krieger C, Quirion R. Excitatory amino acid receptors in human spinal cord. Evaluation in amyotrophic lateral sclerosis patients. Annals of the New York Academy of Sciences. 648: 260-2. PMID 1322080 DOI: 10.1111/J.1749-6632.1992.Tb24550.X  1
1992 Allaoua H, Chaudieu I, Krieger C, Boksa P, Privat A, Quirion R. Alterations in spinal cord excitatory amino acid receptors in amyotrophic lateral sclerosis patients Brain Research. 579: 169-172. PMID 1320444 DOI: 10.1016/0006-8993(92)90758-2  1
1992 Quirion R, Bowen WD, Itzhak Y, Junien JL, Musacchio J, Rothman RB, Tsung-Ping S, Tam SW, Taylor DP. A proposal for the classification of sigma binding sites Trends in Pharmacological Sciences. 13: 85-86. PMID 1315463 DOI: 10.1016/0165-6147(92)90030-A  1
1992 Paré M, Descarries L, Quirion R. Up-regulation of 5-hydroxytryptamine2 and neurokinin-1 receptors associated with serotonin/substance P hyperinnervation in the rat inferior olive. Neuroscience. 51: 97-106. PMID 1281526 DOI: 10.1016/0306-4522(92)90474-G  1
1991 Dauphin F, Richard JW, Seylaz J, Quirion R, Hamel E. Acetylcholine levels and choline acetyltransferase activity in rat cerebrovascular bed after uni- or bilateral sphenopalatine ganglionectomy. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 11: 253-60. PMID 1997497 DOI: 10.1038/Jcbfm.1991.57  1
1991 Gauthier S, Gauthier L, Bouchard R, Quirion R, Sultan S. Treatment of Alzheimer's disease: Hopes and reality Canadian Journal of Neurological Sciences. 18: 439-441. PMID 1933695 DOI: 10.1017/S0317167100032637  1
1991 Krantic S, Dube F, Quirion R, Guerrier P. Pharmacology of the serotonin-induced meiosis reinitiation in Spisula solidissima oocytes. Developmental Biology. 146: 491-8. PMID 1864466 DOI: 10.1016/0012-1606(91)90250-7  1
1991 Chaudieu I, Mount H, Quirion R, Boksa P. Transient postnatal increases in excitatory amino acid binding sites in rat ventral mesencephalon Neuroscience Letters. 133: 267-270. PMID 1667817 DOI: 10.1016/0304-3940(91)90585-H  1
1991 Dam TV, Takeda Y, Krause JE, Quirion R. Comparative autoradiographic distribution of [125I]-neuropeptide gamma and [125I]-neurokinin A binding sites in guinea pig brain. Annals of the New York Academy of Sciences. 632: 377-81. PMID 1659295 DOI: 10.1111/J.1749-6632.1991.Tb33129.X  1
1990 Packard MG, Regenold W, Quirion R, White NM. Post-training injection of the acetylcholine M2 receptor antagonist AF-DX 116 improves memory. Brain Research. 524: 72-6. PMID 2400933 DOI: 10.1016/0006-8993(90)90493-U  1
1990 Araujo DM, Lapchak PA, Meaney MJ, Collier B, Quirion R. Effects of aging on nicotinic and muscarinic autoreceptor function in the rat brain: relationship to presynaptic cholinergic markers and binding sites. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 10: 3069-78. PMID 2398371 DOI: 10.1523/Jneurosci.10-09-03069.1990  1
1990 Gaudreau P, Lavigne GJ, Quirion R. Cholecystokinin antagonists proglumide, lorglumide and benzotript, but not L-364,718, interact with brain opioid binding sites. Neuropeptides. 16: 51-5. PMID 2174522 DOI: 10.1016/0143-4179(90)90029-X  0.72
1990 Martel JC, Alagar R, Robitaille Y, Quirion R. Neuropeptide Y receptor binding sites in human brain. Possible alteration in Alzheimer's disease. Brain Research. 519: 228-35. PMID 2168782 DOI: 10.1016/0006-8993(90)90082-M  0.48
1990 Mount H, Quirion R, Kohn‐Alexander J, Boksa P. Subtypes of excitatory amino acid receptors involved in the stimulation of [3H]dopamine release from cell cultures of rat ventral mesencephalon Synapse. 5: 271-280. PMID 2163120 DOI: 10.1002/Syn.890050404  1
1990 Sarrieau A, Mitchell JB, Lal S, Olivier A, Quirion R, Meaney MJ. Androgen binding sites in human temporal cortex. Neuroendocrinology. 51: 713-6. PMID 2114007 DOI: 10.1159/000125415  0.44
1990 Quirion R, Aubert I, Robitaille Y, Gauthier S, Araujo DM, Chabot JG. Neurochemical deficits in pathological brain aging: specificity and possible relevance for treatment strategies. Clinical Neuropharmacology. 13: S73-80. PMID 2093419 DOI: 10.1097/00002826-199013003-00008  1
1990 Krantic S, Martel JC, Weissmann D, Pujol JF, Quirion R. Quantitative radioautographic study of somatostatin receptors heterogeneity in the rat extrahypothalamic brain. Neuroscience. 39: 127-37. PMID 1982463 DOI: 10.1016/0306-4522(90)90227-U  0.68
1990 Mount H, Boksa P, Chaudieu I, Quirion R. Phencyclidine and related compounds evoked [3H]dopamine release from rat mesencephalic cell cultures by a mechanism independent of the phencyclidine receptor, sigma binding site, or dopamine uptake site Canadian Journal of Physiology and Pharmacology. 68: 1200-1206. PMID 1980428 DOI: 10.1139/Y90-180  1
1990 Araujo DM, Lapchak PA, Collier B, Quirion R. Evidence that somatostatin enhances endogenous acetylcholine release in the rat hippocampus. Journal of Neurochemistry. 55: 1546-55. PMID 1976754 DOI: 10.1111/J.1471-4159.1990.Tb04937.X  1
1990 Mount H, Quirion R, Chaudieu I, Boksa P. Stimulation of Dopamine Release from Cultured Rat Mesencephalic Cells by Naturally Occurring Excitatory Amino Acids: Involvement of Both N‐Methyl‐D‐Aspartate (NMDA) and Non‐NMDA Receptor Subtypes Journal of Neurochemistry. 55: 268-275. PMID 1972390 DOI: 10.1111/J.1471-4159.1990.Tb08848.X  1
1990 Dam TV, Takeda Y, Krause JE, Escher E, Quirion R. gamma-Preprotachykinin-(72-92)-peptide amide: an endogenous preprotachykinin I gene-derived peptide that preferentially binds to neurokinin-2 receptors. Proceedings of the National Academy of Sciences of the United States of America. 87: 246-50. PMID 1688655 DOI: 10.1073/Pnas.87.1.246  1
1990 Flicker LD, Reaves BJ, Das B, Dannies PS, Marinis LD, Mancini A, D’Amico C, Calabró F, Zuppi P, Fiumara C, Barini A, Bahner U, Geiger H, Palkovits M, Ganten D, ... ... Quirion R, et al. Subject Index Vol. 51, 1990 Neuroendocrinology. 51: 730-731. DOI: 10.1159/000125419  0.44
1990 Flicker LD, Reaves BJ, Das B, Dannies PS, Marinis LD, Mancini A, D’Amico C, Calabró F, Zuppi P, Fiumara C, Barini A, Bahner U, Geiger H, Palkovits M, Ganten D, ... ... Quirion R, et al. Contents, Vol. 51, 1990 Neuroendocrinology. 51. DOI: 10.1159/000125399  0.44
1989 Lapchak PA, Araujo DM, Quirion R, Collier B. Effect of chronic nicotine treatment on nicotinic autoreceptor function and N-[3H]methylcarbamylcholine binding sites in the rat brain. Journal of Neurochemistry. 52: 483-91. PMID 2911027 DOI: 10.1111/J.1471-4159.1989.Tb09146.X  1
1989 Lapchak PA, Araujo DM, Quirion R, Collier B. Presynaptic cholinergic mechanisms in the rat cerebellum: evidence for nicotinic, but not muscarinic autoreceptors. Journal of Neurochemistry. 53: 1843-51. PMID 2809595 DOI: 10.1111/J.1471-4159.1989.Tb09251.X  1
1989 Lapchak PA, Araujo DM, Quirion R, Collier B. Binding sites for [3H]AF-DX 116 and effect of AF-DX 116 on endogenous acetylcholine release from rat brain slices. Brain Research. 496: 285-94. PMID 2804636 DOI: 10.1016/0006-8993(89)91075-5  1
1989 Araujo DM, Lapchak PA, Collier B, Quirion R. Localization of interleukin-2 immunoreactivity and interleukin-2 receptors in the rat brain: interaction with the cholinergic system. Brain Research. 498: 257-66. PMID 2790482 DOI: 10.1016/0006-8993(89)91104-9  1
1989 Quirion R, Araujo D, Regenold W, Boksa P. Characterization and quantitative autoradiographic distribution of [3H]acetylcholine muscarinic receptors in mammalian brain. Apparent labelling of an M2-like receptor sub-type Neuroscience. 29: 271-289. PMID 2725859 DOI: 10.1016/0306-4522(89)90057-2  1
1989 Quirion R, Aubert I, Lapchak PA, Schaum RP, Teolis S, Gauthier S, Araujo DM. Muscarinic receptor subtypes in human neurodegenerative disorders: focus on Alzheimer's disease. Trends in Pharmacological Sciences. 80-4. PMID 2694529  1
1989 Araujo DM, Lapchak PA, Collier B, Quirion R. N-[3H]methylcarbamylcholine binding sites in the rat and human brain: relationship to functional nicotinic autoreceptors and alterations in Alzheimer's disease. Progress in Brain Research. 79: 345-52. PMID 2685905 DOI: 10.1016/S0079-6123(08)62494-2  1
1989 Boksa P, Quik M, Mitchell JB, Collier B, O'Neil W, Quirion R. Pharmacological activity of N-methyl-carbamylcholine, a novel acetylcholine receptor agonist with selectivity for nicotinic receptors. European Journal of Pharmacology. 173: 93-108. PMID 2606158 DOI: 10.1016/0014-2999(89)90012-5  1
1989 Krantic S, Martel JC, Weissmann D, Quirion R. Radioautographic analysis of somatostatin receptor sub-type in rat hypothalamus. Brain Research. 498: 267-78. PMID 2571396 DOI: 10.1016/0006-8993(89)91105-0  0.68
1989 Bodnoff SR, Suranyi-Cadotte B, Quirion R, Meaney MJ. A comparison of the effects of diazepam versus several typical and atypical anti-depressant drugs in an animal model of anxiety. Psychopharmacology. 97: 277-9. PMID 2567028 DOI: 10.1007/Bf00442264  1
1989 Mount H, Welner S, Quirion R, Boksa P. Glutamate Stimulation of [3H]Dopamine Release from Dissociated Cell Cultures of Rat Ventral Mesencephalon Journal of Neurochemistry. 52: 1300-1310. PMID 2564426 DOI: 10.1111/J.1471-4159.1989.Tb01879.X  1
1989 Araujo DM, Lapchak PA, Collier B, Chabot JG, Quirion R. Insulin-like growth factor-1 (somatomedin-C) receptors in the rat brain: distribution and interaction with the hippocampal cholinergic system. Brain Research. 484: 130-8. PMID 2540883 DOI: 10.1016/0006-8993(89)90355-7  1
1989 Bodnoff SR, Suranyi-Cadotte BE, Quirion R, Meaney MJ. Role of the central benzodiazepine receptor system in behavioral habituation to novelty. Behavioral Neuroscience. 103: 209-12. PMID 2538132 DOI: 10.1037/0735-7044.103.1.209  1
1989 Reiner A, Brauth SE, Kitt CA, Quirion R. Distribution of mu, delta, and kappa opiate receptor types in the forebrain and midbrain of pigeons. The Journal of Comparative Neurology. 280: 359-82. PMID 2537344 DOI: 10.1002/Cne.902800304  1
1989 Finkel MS, Mendelsohn FAO, Quirion R, Zamir N, Keiser HR. Physiologic Regulation and Distribution of the Renal Vasopressin Receptor Pharmacology. 39: 165-175. PMID 2531425 DOI: 10.1159/000138594  0.56
1988 Araujo DM, Lapchak PA, Collier B, Quirion R. Characterization of N-[3H]methylcarbamylcholine binding sites and effect of N-methylcarbamylcholine on acetylcholine release in rat brain. Journal of Neurochemistry. 51: 292-9. PMID 3379410 DOI: 10.1111/J.1471-4159.1988.Tb04869.X  1
1988 Araujo DM, Lapchak PA, Robitaille Y, Gauthier S, Quirion R. Differential alteration of various cholinergic markers in cortical and subcortical regions of human brain in Alzheimer's disease. Journal of Neurochemistry. 50: 1914-23. PMID 3373218 DOI: 10.1111/J.1471-4159.1988.Tb02497.X  0.92
1988 Sarrieau A, Dussaillant M, Sapolsky RM, Aitken DH, Olivier A, Lal S, Rostène WH, Quirion R, Meaney MJ. Glucocorticoid binding sites in human temporal cortex. Brain Research. 442: 157-60. PMID 3359250 DOI: 10.1016/0006-8993(88)91444-8  0.44
1988 Ali-Khan Z, Quirion R, Robitaille Y, Alizadeh-Khiavi K, Du T. Evidence for increased amyloid enhancing factor activity in Alzheimer brain extract. Acta Neuropathologica. 77: 82-90. PMID 3239378 DOI: 10.1007/BF00688246  0.48
1988 Bodnoff SR, Suranyi-Cadotte B, Aitken DH, Quirion R, Meaney MJ. The effects of chronic antidepressant treatment in an animal model of anxiety. Psychopharmacology. 95: 298-302. PMID 3137614 DOI: 10.1007/Bf00181937  0.44
1988 Leblanc R, Gauthier S, Gauvin M, Quirion R, Palmour R, Masson H. Neurobehavioral effects of intrathecal somatostatinergic treatment in subhuman primates. Neurology. 38: 1887-90. PMID 2904131 DOI: 10.1212/Wnl.38.12.1887  1
1987 Gaudreau P, St-Pierre S, Pert CB, Quirion R. Structure-activity studies of C- and N-terminal fragments of cholecystokinin 26-33 in guinea pig isolated tissues. Neuropeptides. 10: 9-18. PMID 3670570 DOI: 10.1016/0143-4179(87)90084-9  1
1987 Boksa P, Quirion R. [3H]N-methyl-carbamylcholine, a new radioligand specific for nicotinic acetylcholine receptors in brain European Journal of Pharmacology. 139: 323-333. PMID 3666008 DOI: 10.1016/0014-2999(87)90590-5  1
1987 Gaudreau P, Quirion R, St-Pierre S, Chiueh CC, Pert A. Localization of cholecystokinin receptors in relation to the nigrostriatal and mesolimbic dopaminergic pathways. Neuropeptides. 9: 283-93. PMID 3614556 DOI: 10.1016/0143-4179(87)90003-5  0.32
1987 Contreras PC, Quirion R, Gehlert DR, Contreras ML, O'Donohue TL. Autoradiographic distribution of non-dopaminergic binding sites labeled by [3H]haloperidol in rat brain. Neuroscience Letters. 75: 133-40. PMID 3033560 DOI: 10.1016/0304-3940(87)90286-2  0.36
1987 Quirion R, Robitaille Y, Martial J, Chabot JG, Lemoine P, Pilapil C, Dalpé M. Human brain receptor autoradiography using whole hemisphere sections: a general method that minimizes tissue artefacts. Synapse (New York, N.Y.). 1: 446-54. PMID 2850625 DOI: 10.1002/Syn.890010508  0.68
1987 Quirion R, Welner S, Gauthier S, Bédard P. Neurotensin receptor binding sites in monkey and human brain: autoradiographic distribution and effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine treatment. Synapse. 1: 559-566. PMID 2843996 DOI: 10.1002/Syn.890010608  0.92
1987 Bodnoff SR, Suranyi-Cadotte B, Quirion R, Meaney MJ. Postnatal handling reduces novelty-induced fear and increases [3H]flunitrazepam binding in rat brain. European Journal of Pharmacology. 144: 105-7. PMID 2830116 DOI: 10.1016/0014-2999(87)90016-1  1
1987 Pilapil C, Welner S, Magnan J, Gauthier S, Quirion R. Autoradiographic distribution of multiple classes of opioid receptor binding sites in human forebrain Brain Research Bulletin. 19: 611-615. PMID 2825931 DOI: 10.1016/0361-9230(87)90080-3  0.92
1986 Etienne P, Robitaille Y, Wood P, Gauthier S, Nair NP, Quirion R. Nucleus basalis neuronal loss, neuritic plaques and choline acetyltransferase activity in advanced Alzheimer's disease. Neuroscience. 19: 1279-91. PMID 3822122 DOI: 10.1016/0306-4522(86)90142-9  0.92
1986 Quirion R, Boksa P. Autoradiographic distribution of muscarinic [3H]Acetylcholine receptors in rat brain: Comparison with antagonists European Journal of Pharmacology. 123: 170-172. PMID 3754816 DOI: 10.1016/0014-2999(86)90702-8  1
1986 Gauthier S, Robitaille Y, Quirion R, Leblanc R. Antemortem laboratory diagnosis of Alzheimer's disease. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 10: 391-403. PMID 3541044 DOI: 10.1016/0278-5846(86)90013-8  0.92
1986 Wise RA, Jenck F, Gratton A, Quirion R. Opiate receptor subtypes associated with the brain mechanisms of feeding and reward. Nida Research Monograph. 71: 165-72. PMID 3025734  1
1986 Brauth SE, Kitt CA, Reiner A, Quirion R. Neurotensin binding sites in the forebrain and midbrain of the pigeon. The Journal of Comparative Neurology. 253: 358-73. PMID 3025271 DOI: 10.1002/Cne.902530306  1
1986 Contreras PC, Quirion R, O'Donohue TL. Autoradiographic distribution of phencyclidine receptors in the rat brain using [3H]1-(1-(2-thienyl)cyclohexyl)piperidine ([3H]TCP). Neuroscience Letters. 67: 101-6. PMID 3014394 DOI: 10.1016/0304-3940(86)90380-0  0.36
1986 Quirion R, Gaudreau P. Strategies in neuropeptide receptor binding research. Neuroscience and Biobehavioral Reviews. 9: 413-20. PMID 2999656 DOI: 10.1016/0149-7634(85)90019-3  0.56
1986 Suranyi-Cadotte BE, Gauthier S, Lafaille F, DeFlores S, Dam TV, Nair NP, Quirion R. Platelet 3H-imipramine binding distinguishes depression from Alzheimer dementia. Life Sciences. 37: 2305-11. PMID 2999549 DOI: 10.1016/0024-3205(85)90022-0  0.44
1986 Quirion R, Martel JC, Robitaille Y, Etienne P, Wood P, Nair NP, Gauthier S. Neurotransmitter and receptor deficits in senile dementia of the Alzheimer type. The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques. 13: 503-10. PMID 2878714 DOI: 10.1017/S0317167100037215  0.92
1986 Gauthier S, Leblanc R, Robitaille Y, Quirion R, Carlsson G, Beaulieu M, Bouchard R, Dastoor D, Ervin F, Gauthier L. Transmitter-replacement therapy in Alzheimer's disease using intracerebroventricular infusions of receptor agonists. The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques. 13: 394-402. PMID 2878712 DOI: 10.1017/S0317167100036969  1
1985 Quirion R, Lal S, Nair NP, Stratford JG, Ford RM, Olivier A. Comparative autoradiographic distribution of calcium channel antagonist binding sites for 1,4-dihydropyridine and phenylalkylamine in rat, guinea pig and human brain. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 9: 643-9. PMID 3003805 DOI: 10.1016/0278-5846(85)90033-8  1
1985 French ED, Pilapil C, Quirion R. Phencyclidine binding sites in the nucleus accumbens and phencyclidine-induced hyperactivity are decreased following lesions of the mesolimbic dopamine system European Journal of Pharmacology. 116: 1-9. PMID 2996909 DOI: 10.1016/0014-2999(85)90178-5  1
1985 Gaudreau P, St-Pierre S, Pert CB, Quirion R. Cholecystokinin receptors in mammalian brain. A comparative characterization and visualization. Annals of the New York Academy of Sciences. 448: 198-219. PMID 2992345 DOI: 10.1111/J.1749-6632.1985.Tb29919.X  1
1985 Wolf SS, Moody TW, Quirion R, O'Donohue TL. Biochemical characterization and autoradiographic localization of central substance P receptors using [125I]physalaemin Brain Research. 332: 299-307. PMID 2581653 DOI: 10.1016/0006-8993(85)90598-0  1
1985 Rostène W, Quirion R, Beaudet A, Mazière B. Images des récepteurs des messagers chimiques et des médicaments dans le cerveau M S-Medecine Sciences. 1: 419. DOI: 10.4267/10608/3393  0.32
1984 Park CH, Massari VJ, Quirion R, Tizabi Y, Shults CW, O'Donohue TL. Characteristics of 3H-substance P binding sites in rat brain membranes. Peptides. 5: 833-6. PMID 6208537 DOI: 10.1016/0196-9781(84)90031-7  1
1984 Quirion R, DiMaggio DA, French ED, Contreras PC, Shiloach J, Pert CB, Everist H, Pert A, O'Donohue TL. Evidence for an endogenous peptide ligand for the phencyclidine receptor. Peptides. 5: 967-73. PMID 6095223 DOI: 10.1016/0196-9781(84)90124-4  1
1984 O'Donohue TL, Massari VJ, Pazoles CJ, Chronwall BM, Shults CW, Quirion R, Chase TN, Moody TW. A role for bombesin in sensory processing in the spinal cord. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 4: 2956-62. PMID 6094746 DOI: 10.1523/Jneurosci.04-12-02956.1984  1
1984 Finkel MS, Quirion R, Pert C, Patterson RE. Characterization and autoradiographic distribution of the beta-adrenergic receptor in the rat lung. Pharmacology. 29: 247-54. PMID 6093158 DOI: 10.1159/000138020  1
1984 Shults CW, Quirion R, Chronwall B, Chase TN, O'Donohue TL. A comparison of the anatomical distribution of substance P and substance P receptors in the rat central nervous system. Peptides. 5: 1097-128. PMID 6085163 DOI: 10.1016/0196-9781(84)90177-3  1
1983 Zerbe RL, Bayorh MA, Quirion R, Kopin IJ. The role of vasopressin suppression in phencyclidine-induced diuresis. Pharmacology. 26: 73-8. PMID 6844390 DOI: 10.1159/000137786  0.4
1983 Quirion R, Pert CB. Properties of the phencyclidine (PCP) receptors. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 7: 451-6. PMID 6320296 DOI: 10.1016/0278-5846(83)90010-6  1
1983 Quirion R, Finkel MS, Mendelsohn FAO, Zamir N. Localization of opiate binding sites in kidney and adrenal gland of the rat. Life Sciences. 33: 299-302. PMID 6319881 DOI: 10.1016/0024-3205(83)90502-7  0.56
1983 Gaudreau P, Quirion R, St-Pierre S, Pert CB. Characterization and visualization of cholecystokinin receptors in rat brain using [3H]pentagastrin. Peptides. 4: 755-62. PMID 6318206 DOI: 10.1016/0196-9781(83)90032-3  1
1983 Rice KC, Konicki PE, Quirion R, Burke TR, Pert CB. Synthesis and pharmacological characterization of (+/-)-5,9 alpha-dimethyl-2-[2-(4-fluorophenyl)ethyl]-2'-hydroxy-6,7-benzomorphan (fluorophen), a ligand suitable for visualization of opiate receptors in vivo. Journal of Medicinal Chemistry. 26: 1643-5. PMID 6313921  1
1983 Wolf SS, Moody TW, Quirion R, Shults CW, Chase TN, O'Donohue TL. Autoradiographic visualization of substance P receptors in rat brain European Journal of Pharmacology. 91: 157-158. PMID 6311571 DOI: 10.1016/0014-2999(83)90066-3  1
1983 Quirion R, Pert CB. Modulation of phencyclidine receptor sensitivity. Nida Research Monograph. 43: 217-23. PMID 6308454  1
1983 Gaudreau P, Quirion R, St-Pierre S, Pert CB. Tritium-sensitive film autoradiography of [3H]cholecystokinin-5/pentagastrin receptors in rat brain. European Journal of Pharmacology. 87: 173-4. PMID 6301853 DOI: 10.1016/0014-2999(83)90071-7  1
1983 Altura BT, Quirion R, Pert CB, Altura BM. Phencyclidine ("angel dust") analogs and sigma opiate benzomorphans cause cerebral arterial spasm. Proceedings of the National Academy of Sciences of the United States of America. 80: 865-9. PMID 6298779 DOI: 10.1073/Pnas.80.3.865  1
1983 Quirion R, Shults CW, Moody TW, Pert CB, Chase TN, O'Donohue TL. Autoradiographic distribution of substance P receptors in rat central nervous system. Nature. 303: 714-6. PMID 6190094 DOI: 10.1038/303714A0  1
1983 Quirion R, Weiss AS, Pert CB. Comparative pharmacological properties and autoradiographic distribution of [3H]ethylketocyclazocine binding sites in rat and guinea pig brain. Life Sciences. 33: 183-6. PMID 6141485 DOI: 10.1016/0024-3205(83)90473-3  1
1983 Pert CB, Quirion R. The phencyclidine receptor Trends in Pharmacological Sciences. 4: 12-13. DOI: 10.1016/0165-6147(83)90265-1  1
1983 Wolf SS, Moody TW, Quirion R, Shults CW, Chase TN, O'Donohue TL. Autoradiographic visualization of substance receptors in rat brain European Journal of Pharmacology. 91: 157-158. DOI: 10.1016/0014-2999(83)90383-7  1
1982 Quirion R, Pert CB. Certain calcium antagonists are potent displacers of [3H]phencyclidine (PCP) binding in rat brain. European Journal of Pharmacology. 83: 155-6. PMID 7128698 DOI: 10.1016/0014-2999(82)90305-3  1
1982 Quirion R, Bowen WD, Herkenham M, Pert CB. Visualization and solubilization of rat brain opiate receptors with a "kappa" ligand selectivity pattern. Cellular and Molecular Neurobiology. 2: 333-46. PMID 6305502 DOI: 10.1007/Bf00710853  1
1982 Shults CW, Quirion R, Jensen RT, Moody TW, O'Donohue TL, Chase TN. Autoradiographic localization of substance P receptors using 125I substance P Peptides. 3: 1073-1075. PMID 6300806 DOI: 10.1016/0196-9781(82)90076-6  1
1982 Olgiati V, Quirion R, Bowen WD, Pert CB. Characterization of type 2 opiate receptors. Life Sciences. 31: 1675-8. PMID 6296570 DOI: 10.1016/0024-3205(82)90183-7  1
1982 Quirion R, Bayorh MA, Zerbe RL, Pert CB. Chronic phencyclidine treatment decreases phencyclidine and dopamine receptors in rat brain. Pharmacology, Biochemistry, and Behavior. 17: 699-702. PMID 6294678 DOI: 10.1016/0091-3057(82)90349-5  1
1982 Quirion R, Gaudreau P, St-Pierre S, Rioux F, Pert CB. Autoradiographic distribution of [3H]neurotensin receptors in rat brain: visualization by tritium-sensitive film. Peptides. 3: 757-63. PMID 6294631 DOI: 10.1016/0196-9781(82)90011-0  1
1982 Quirion R, Hammer RP, Herkenham M, Pert CB. Autoradiographic localization of the phencyclidine/sigma "opiate" receptor in rat brain. Nida Research Monograph. 41: 178-83. PMID 6289117  1
1982 Quirion R, Kiso Y, Pert CB. Syndyphalin SD-25: a highly selective ligand for mu opiate receptors. Febs Letters. 141: 203-6. PMID 6284554 DOI: 10.1016/0014-5793(82)80047-1  1
1982 Hammer RP, Herkenham M, Pert CB, Quirion R. Correlation of regional brain metabolism with receptor localization during ketamine anesthesia: combined autoradiographic 2-[3H]deoxy-D-glucose receptor binding technique. Proceedings of the National Academy of Sciences of the United States of America. 79: 3067-70. PMID 6283555 DOI: 10.1073/Pnas.79.9.3067  1
1982 Quirion R, Pert CB. Amantadine modulates phencyclidine binding site sensitivity in rat brain. Experientia. 38: 955-6. PMID 6215256 DOI: 10.1007/Bf01953674  1
1982 Jolicoeur FB, Barbeau A, Quirion R, Rioux F, St‐Pierre S. PHARMACOLOGICAL EVIDENCE FOR A HETEROGENEITY OF RECEPTORS UNDERLYING VARIOUS CENTRAL AND PERIPHERAL EFFECTS OF NEUROTENSIN Annals of the New York Academy of Sciences. 400: 440-442. DOI: 10.1111/j.1749-6632.1982.tb31610.x  1
1982 Quirion R, Kiso Y, Pert CB. Syndyphalin SD-25: A highly selective ligand for μ opiate receptors (1982) FEBS Letters 141,203-206 Febs Letters. 148: 171.  1
1981 Jolicoeur FB, Barbeau A, Rioux F, Quirion R, St-Pierre S. Differential neurobehavioral effects of neurotensin and structural analogues Peptides. 2: 171-175. PMID 7291042 DOI: 10.1016/S0196-9781(81)80031-9  1
1981 St-Pierre S, Lalonde JM, Gendreau M, Quirion R, Regoli D, Rioux F. Synthesis of peptides by the solid-phase method. 6. Neurotensin, fragments, and analogues. Journal of Medicinal Chemistry. 24: 370-6. PMID 7265123 DOI: 10.1002/Chin.198134331  0.64
1981 Rioux F, Quirion R, St-Pierre S, Regoli D, Jolicoeur FB, Bélanger F, Barbeau A. The hypotensive effect of centrally administered neutrotensin in rats European Journal of Pharmacology. 69: 241-247. PMID 7215426 DOI: 10.1016/0014-2999(81)90469-6  1
1981 Quirion R, Rice KC, Skolnick P, Paul S, Pert CB. Stereospecific displacement of [3H]phencyclidine (PCP) receptor binding by an enantiomeric pair of PCP analogs. European Journal of Pharmacology. 74: 107-8. PMID 6459238 DOI: 10.1016/0014-2999(81)90330-7  1
1981 Quirion R, Hammer RP, Herkenham M, Pert CB. Phencyclidine (angel dust)/sigma "opiate" receptor: visualization by tritium-sensitive film. Proceedings of the National Academy of Sciences of the United States of America. 78: 5881-5. PMID 6272322 DOI: 10.1073/Pnas.78.9.5881  1
1981 Quirion R, Pert CB. Dynorphins: similar relative potencies on mu, delta- and kappa-opiate receptors. European Journal of Pharmacology. 76: 467-8. PMID 6120085 DOI: 10.1016/0014-2999(81)90125-4  1
1981 Quirion R, Rioux F, St-Pierre S, Bélanger F, Jolicoeur FB, Barbeau A. Hypotensive effects of centrally and peripherally administered neurotensin and neurotensin derivatives in rats Neuropeptides. 1: 253-259. DOI: 10.1016/0143-4179(81)90003-2  1
1980 Khalaf IM, Rioux F, Quirion R, Elhilali MM. Intravesical prostaglandin: release and effect of bladder instillation on some micturition parameters. British Journal of Urology. 52: 351-6. PMID 7427008 DOI: 10.1111/J.1464-410X.1980.TB03059.X  1
Show low-probability matches.